Skip to main content
BioMedical Engineering OnLine logoLink to BioMedical Engineering OnLine
. 2007 Apr 20;6:14. doi: 10.1186/1475-925X-6-14

A computational model of skeletal muscle metabolism linking cellular adaptations induced by altered loading states to metabolic responses during exercise

Ranjan K Dash 3,4,5,#, John A DiBella II 1,#, Marco E Cabrera 1,2,3,4,
PMCID: PMC1868741  PMID: 17448235

Abstract

Background

The alterations in skeletal muscle structure and function after prolonged periods of unloading are initiated by the chronic lack of mechanical stimulus of sufficient intensity, which is the result of a series of biochemical and metabolic interactions spanning from cellular to tissue/organ level. Reduced activation of skeletal muscle alters the gene expression of myosin heavy chain isoforms to meet the functional demands of reduced mechanical load, which results in muscle atrophy and reduced capacity to process fatty acids. In contrast, chronic loading results in the opposite pattern of adaptations.

Methods

To quantify interactions among cellular and skeletal muscle metabolic adaptations, and to predict metabolic responses to exercise after periods of altered loading states, we develop a computational model of skeletal muscle metabolism. The governing model equations – with parameters characterizing chronic loading/unloading states- were solved numerically to simulate metabolic responses to moderate intensity exercise (WR ≤ 40% VO2 max).

Results

Model simulations showed that carbohydrate oxidation was 8.5% greater in chronically unloaded muscle compared with the loaded muscle (0.69 vs. 0.63 mmol/min), while fat oxidation was 7% higher in chronically loaded muscle (0.14 vs. 0.13 mmol/min), during exercise. Muscle oxygen uptake (VO2) and blood flow (Q) response times were 29% and 44% shorter in chronically loaded muscle (0.4 vs. 0.56 min for VO2 and 0.25 vs. 0.45 min for Q).

Conclusion

The present model can be applied to test complex hypotheses during exercise involving the integration and control of metabolic processes at various organizational levels (cellular to tissue) in individuals who have undergone periods of chronic loading or unloading.

Background

Living organisms have the inherent capacity to adapt to their environment by altering the structural and functional properties of their tissues and/or organ systems. The adaptive process starts by having specific genes and their products undergo altered expression in order to meet the demands imposed by the environmental conditions. In particular, skeletal muscle adapts by altering the contractile protein myosin heavy chain (MHC) in quantity and type of isoform in response to the chronic mechanical perturbation (loading/unloading) imposed on it [1-5]. Thus, skeletal muscle is capable of adapting to interventions involving a chronic mechanical stress which is either increased (e.g., endurance or resistance exercise) or reduced (e.g., chronic inactivity, limb immobilization, or microgravity exposure) by regulating the expression of key enzymes and transport proteins.

Chronically increased physical activity (loading) at levels requiring 70–80% of maximal aerobic capacity, typical of endurance training, has shown to increase muscle capillarization and mitochondrial density and to upregulate the mitochondrial enzyme systems of the Krebs cycle and the electron transport chain [6-11]. Endurance training or chronic loading also lowers glucose uptake and the rate of glycogen breakdown leading to reduced rates of glycolytically-derived pyruvate, pyruvate oxidation, and lactate production [12-14]. In addition, chronic loading increases the expression of the enzymes involved in fatty acid activation, translocation, and oxidation leading to an increased rate of fatty acid oxidation [15-18]. As a consequence, chronically-loaded individuals rely more on fats as the main source of fuel for ATP synthesis, which is offset by a reduction in the relative contribution of intramuscular glycogen [16,19,20].

In contrast, when skeletal muscle is continuously unloaded – as it occurs during microgravity exposure or bed rest, or during chronically reduced physical activity (e.g., limb immobilization or detraining) – the opposite patterns of transformation in muscle metabolic characteristics occur. Chronic unloading induces small reductions in muscle capillarization and mitochondrial density [8,21], as well as a 20–50% reduction in the maximal activities of oxidative enzymes [22,23]. Unloading also leads to an increased contribution from intra-muscular carbohydrates for ATP production, resulting in a greater rate of lactate formation during exercise [22,24]. Associated with this increased reliance in glycogen breakdown is the reduced production of acetyl-CoA from fatty acid oxidation, which is accentuated during periods of increased physical activity [18,22,24]. In addition to these metabolic alterations, chronic unloading results in a significant reduction in fibers cross sectional area in the quadriceps muscle, which leads to a decline in whole muscle volume [8,21], as well as reduced muscle strength and endurance [21,23,25]. Prolonged chronic unloading enhances these alterations leading to further deterioration in muscle function until complete adaptation to physical and energetic demands of the new environment is established [21,23,25].

Skeletal muscle adaptations to chronic loading and unloading also result in different dynamic metabolic responses to acute exercise. Even though the amount of oxygen taken up by muscle cells during the steady-state response (VO2 ss) of a sub-maximal constant work rate exercise bout of moderate intensity (WR ≤ 40% VO2 max) remains the same regardless of conditioning status of the muscle [26,27], the transient response is different in individuals who have undergone chronic unloading vs. loading. While chronic unloading increases the time needed to reach VO2 ss when compared to controls, endurance training or chronic loading decreases this response time [27]. The dynamic response of phosphocreatine (PCr) breakdown at exercise onset shows similar behavior, with the loaded muscle buffer ATP changes and deplete PCr stores faster [6,11].

The changes in the time profiles of step-responses of various metabolic variables elicited by periods of chronic loading or unloading illustrate the significance of (i) collecting and analyzing dynamic information in the evaluation and characterization of physiological responses to exercise under conditions representing altered loading states, and (ii) linking cellular alterations to the metabolic responses observed in contracting skeletal muscle. Unfortunately, limited dynamic physiological data have been collected under chronic unloading (e.g., space travel, bed rest, limb immobilization) and loading (e.g., endurance or resistance exercise) conditions at the cellular and tissue levels. Moreover, it is not clear how the chain of events involved in the adaptive process is linked to manifestations of altered protein expressions in response to altered loading states in skeletal muscle.

To predict dynamic information on the effects of chronic unloading/loading states on skeletal muscle cellular metabolic responses to constant work rate exercise, a validated physiologically-based computational model of skeletal muscle bioenergetics is required that accounts for the instantaneous increase in ATP turnover rate (acute response) and tight coupling between energy demand-energy supply systems and integrates alterations induced by chronic loading/unloading states (chronic adaptation) from the cellular to the tissue level. The objectives of the present study are therefore (i) to extend a previously developed mathematical model of skeletal muscle metabolism under normal conditions [28,29] by adding necessary biochemical elements which have been documented to be altered after periods of loading or unloading, and (ii) to predict the metabolic responses to constant work rate exercise of moderate intensity in both chronic loaded and unloaded states. Specifically, by simulating these responses under loaded, unloaded, and control states, we investigated whether feedback activation by ADP, Pi and NADH is sufficient to match ATP supply to demand at the onset of exercise or a parallel activation mechanism is required for such matching. In addition, we investigated whether specific changes in skeletal muscle enzyme content/activity induced by a chronic increase or decrease in mechanical loading can lead to alterations in the patterns of fuel oxidation during acute exercise.

Method

Model development

The mathematical model of skeletal muscle metabolism is developed here by extending a previously published model [28,29], which was primarily developed in the context of whole-body metabolism. In the current model, we identified and included many more key intermediate metabolites and regulatory enzymes along the biochemical pathways (Fig 1) and redefined the metabolic reaction flux expressions following Michaelis-Menten formalism [30] to better mimic the reality of saturable enzyme kinetics. In addition, we incorporated into the model information on enzyme kinetics, which is altered after periods of chronic loading or unloading. Changes in these parameter values – from their control values representing enzyme activity/affinity in normal sedentary muscle – alter the flux expressions and mass balance equations resulting in changes in the dynamics of specific metabolites and flux rates in response to an input. A simplified map of the biochemical pathways in skeletal muscle is schematized in Figure 1. The lumped reactions in the pathways were generated by stoichiometrically coupling many elementary reactions. These include the energy controller pairs ATP-ADP and NADH-NAD+ (co-substrate co-product pairs), the ratios of which modulate the associated reaction fluxes [31,32]. Many lumped reactions were considered irreversible as the corresponding regulatory enzymes in vivo usually have large equilibrium constants in favor of the product formation [33].

Figure 1.

Figure 1

Schematic diagram of biochemical pathways depicting various chemical reactions and species involved in the cellular metabolism of skeletal muscle. The pathways involve 26 lumped reactions among 30 species out of which 9 species undergo the blood-tissue exchange.

By linking changes in the work rate on a cycle ergometer to the rate of ATP turnover and by inducing parallel activating changes in several key variables (e.g., blood flow, active muscle volume, enzyme activities), we anticipate to successfully simulate exercise responses with our phenomenological model of skeletal muscle metabolism. This empirical parallel activation mechanism has also been described in other phenomenological models in the literature [29,34-37] for simulating acute exercise responses and matching ATP supply to ATP demand during exercise. Though the mechanism of parallel activation has not been proven or disproved experimentally, it is attributed to the stimulation of the activities of key regulatory enzymes by the levels of free calcium [Ca2+] and/or hormones (catecholamine, epinephrine) [29,34-37], which are control by neural stimulation [38-40]. In this model, the active muscle volume is expressed as a function of work rate in order to accurately simulate the extent of muscle recruitment with increased work rate [41,42]. In addition, we assume that, during exercise at work rates ranging from 30–45% VO2 max, the arterial substrate concentrations remain unaffected by the venous effluent due to the reestablishment of homeostasis by other organ systems such as heart, liver, or non-active muscle [29,43-45].

The governing model equations are developed here by assuming a multi-compartmental model structure for skeletal muscle as schematized in Figure 2. It consists of a spatially-lumped capillary blood domain which exchanges micro-nutrients and metabolic waste products with a spatially-lumped domain of tissue cells (cytosol and mitochondria); these two domains are separated by a spatially-lumped interstitial fluid (ISF) domain. Due to lack of information on metabolite concentrations and enzyme activities at sub-cellular level, we do not differentiate between the cytosolic and mitochondrial species in this model, that is, we assume that the metabolites and enzymes are uniformly distributed throughout the cellular domain.

Figure 2.

Figure 2

Schematic diagram of the structure of the model for blood-tissue exchange and cellular metabolism in skeletal muscle. The model accounts for 30 chemical species in tissue cells. A total of 9 species (glucose, lactate, pyruvate, alanine, triglycerides, glycerol, free fatty acid, carbon dioxide, and oxygen) undergo blood-tissue exchange.

It is noteworthy to mention here that the capillary blood and tissue ISF volumes (Vb and Visf) are very small compared to the tissue cells volume (Vc); typically, Vb and Visf are only about 7% and 13% of Vtot, whereas Vc is about 80% of Vtot, where Vtot denote the total muscle volume (e.g., see Ref. [46] and the related references therein). Furthermore, the rate of species transport across the capillary and tissue cell membranes are usually very fast (i.e., the inter-domain transport fluxes Jb↔isf,j and Jisf↔c,j are very large), so that the three parallel compartments can be assumed to be in equilibrium almost instantaneously. These lead to the following approximations:

Vb(dCb, j/dt) ≪ 1   and   Visf (dCisf, j/dt) ≪ 1
Q(Ca, j - Cv, j) ≈ Jbisf, j Jisfc, j Jbc, j
Cb, j = Cv, j = σcap, jCisf, j     and     Cisf, j = σc, jCc, j

where Cb,j, Cisf,j and Cc,j are the species concentrations in capillary blood, ISF and tissue cells; Ca,j and Cv,j are the input arterial and output venous species concentrations; σcap,j and σc,j are the partition coefficients across the capillary and tissue cell membranes; Q is the blood flow.

The dynamic mass balance equation for the chemical species j in the well-mixed tissue cells domain [28,29] can then be written as

VcdCc,jdt=pβj,pφpuβj,uφu+Q(Ca,jσjCc,j),j=1,2,...,NS     MathType@MTEF@5@5@+=feaafiart1ev1aqatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaafaqabeqacaaabaGaemOvay1aaSbaaSqaaiabdogaJbqabaGcdaWcaaqaaiabdsgaKjabdoeadnaaBaaaleaacqWGJbWycqGGSaalcqWGQbGAaeqaaaGcbaGaemizaqMaemiDaqhaaiabg2da9maaqafabaacciGae8NSdi2aaSbaaSqaaiabdQgaQjabcYcaSiabdchaWbqabaGccqWFgpGzdaWgaaWcbaGaemiCaahabeaakiabgkHiTaWcbaGaemiCaahabeqdcqGHris5aOWaaabuaeaacqWFYoGydaWgaaWcbaGaemOAaOMaeiilaWIaemyDauhabeaakiab=z8aMnaaBaaaleaacqWG1bqDaeqaaaqaaiabdwha1bqab0GaeyyeIuoakiabgUcaRiabdgfarnaabmaabaGaem4qam0aaSbaaSqaaiabdggaHjabcYcaSiabdQgaQbqabaGccqGHsislcqWFdpWCdaWgaaWcbaGaemOAaOgabeaakiabdoeadnaaBaaaleaacqWGJbWycqGGSaalcqWGQbGAaeqaaaGccaGLOaGaayzkaaGaeiilaWcabaGaemOAaOMaeyypa0JaeGymaeJaeiilaWIaeGOmaiJaeiilaWIaeiOla4IaeiOla4IaeiOla4IaeiilaWIaemOta40aaSbaaSqaaiabdofatbqabaaaaOGaeeiiaaIaeeiiaaIaeeiiaaIaeeiiaacaaa@74BB@

where σj = σcap,jσc,j is the effective partition coefficient across the blood and tissue cell exchange barrier; φp and φu are the metabolic reaction fluxes of the reactions processes that produce and utilize the species j, and βj,p and βj,u are the corresponding stoichiometric coefficients; NS = 30 is the total number of chemical species in the cellular domain. The first two terms in Eq. (2) define the net metabolic reaction rate of the chemical species j inside the tissue cells (Rj = Pj - Uj, where Pj is the production of species j and Uj is the utilization of species j), whereas the term Q(Ca,j - σjCc,j) defines the net uptake or release of the chemical species j by the tissue cells. The dynamic mass balance equations of all the 30 chemical species are given in Appendix A.

The underlying viewpoint in modeling complex in vivo metabolic systems, such as skeletal muscle, is based on a top-down systems approach [28,29,32,47,48]. To define the metabolic reaction fluxes using such an approach, we consider a general irreversible bi-bi substrate to product enzymatic reaction coupled with energy controller pairs associated with the reaction as co-substrates and co-products:

graphic file with name 1475-925X-6-14-i2.gif

where E1 and E2 are the ATP and ADP or vice-versa (PS±: phosphorylation state) or NADH and NAD+ or vice versa (RS±: redox state). Any biochemical conversion process that is coupled to ATP ↔ ADP or NAD+ ↔ NADH interconversions, such as pyruvate oxidation or oxidative phosphorylation, can affect the dynamics of these control metabolites. So, even though E1 and E2 are co-substrates and co-products, their ratios have been proven to play major roles in the modulation of the associated reaction fluxes [28,29,32,47,48] (see the flux expressions: Eqs. 4 and 5). Though not all, many of the lumped reactions in the metabolic pathways in Figure 1 are special cases of this general reaction. As part of a general formalism, reversible reactions are decomposed into two irreversible reactions. Considering Michaelis-Menten formalism of a rapid equilibrium, random binding, bi-bi enzymatic irreversible reaction [30,49,50], and accounting for product inhibition [31], the reaction flux can be phenomenologically expressed as

φX+YV+W=VX+YV+Weffective[CXKXCYKY][1+CXKX+CYKY+CXKXCYKY+CVKV+CWKW+CVKVCWKW]1 MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@8D8D@

where the effective reaction velocity due to the coupling of the energy controller pairs is given by a phenomenological expression of the form

VX+YV+Weffective=VX+YV+W[CE1/CE2][KE1/E2+CE1/CE2]1 MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@68AF@

VX+Y→V+W is the maximal velocity or flux of the reaction and K's are the phenomenological Michaelis-Menten constants for the associated reactants or the coupled energy controller ratios E1/E2: ATP/ADP, ADP/ATP, NADH/NAD+, or NAD+/NADH. So, the in vivo effective velocity of the reaction is controlled by the coupled energy controller ratios CE1/CE2 (if coupled). As in our previous models [28,29,47,48], we choose to express controllers in ratio form to increase the sensitivity of their regulatory properties on actual in vivo reaction velocities. While AMP is not directly involved in any reaction outside of the adenylate kinase system, we coupled the energy controller ratio CAMP/CATP to the reaction flux describing glycogen breakdown, since it is well-known that AMP has important allosteric control over the enzymes catalyzing the above lumped reaction [49-51]. Even though the reaction flux expressions are "phenomenological", expressing the fluxes in the Michaelis-Menten form serves two purposes: (i) it best describes the kinetic behavior of enzymatic reactions seen experimentally, and (ii) it establishes upper and lower bounds for the fluxes [30].

It is to be noted here that Eqs. (4) and (5) serve as the general flux expression for the lumped metabolic reaction (3). If the energy controller pair E1 and E2 is not coupled to the reaction under consideration as co-substrate/co-product, then the reaction flux does not depend on the ratio CE1/CE2. Therefore, not all, but only those reactions stoichiometrically associated with changes in phosphorylation (CATP/CADP or CADP/CATP) and/or redox (CNADH/CNAD+ or CNAD+/CNADH) ratios have their flux rate modulated by these controllers. The phenomenological metabolic reaction flux expressions of all the 26 lumped reactions considered in this model are given in Appendix B.

As modeled, a biochemical conversion process coupled to NAD+ ↔ NADH interconversions affects the redox state CNAD+/CNADH and indirectly modulates the flux of any other reaction process coupled to NAD+ ↔ NADH interconversions. Similar interrelationships exist among all processes coupled to ATP ↔ ADP interconversions. In the control of energy metabolism, ATP acts as an inhibitor, while ADP acts as a stimulator. This approach of modeling the regulation of metabolic processes provides not only a feedback control of specific conversion processes, but also integrates various metabolic pathways for energy (ATP) generation. As described below, the feedback controls by the products ADP, Pi and NADH may not alone be sufficient to match ATP supply to ATP demand during exercise, in which case, a parallel activation of different metabolic pathways is required for such matching.

Parallel activation scheme during exercise

The rate at which ATP is utilized is set by the increase in mechanical power needed to perform a particular physical task. During exercise at a constant work rate, a proportionate recruitment of muscle fibers occurs, and steady contraction can be maintained only if the ATP demand is matched. As the ATP turnover rate increases, flux through the energy-providing pathways of carbohydrates and fats rises to increase the rate of ATP production in order to match the rate of ATP utilization [8,52]. This increase in the ATP turnover rate is met through (i) increased delivery of arterial species by increased blood flow and (ii) feedback and/or feedforward activation of latent enzyme molecules associated with various reactions. The feedback control mechanisms (though not mechanistically detailed) are built-in into the flux expressions through phosphorylation (CATP/CADP or CADP/CATP) and/or redox (CNADH/CNAD+ or CNAD+/CNADH) ratios. So we discuss here and incorporate into the model the feedforward control mechanisms in an empirical/implicit fashion to simultaneously activate different metabolic pathways leading to ATP generation (glycolysis and glycogenolysis, pyruvate oxidation, beta oxidation, TCA cycle, and oxidative phosphorylation) through external effectors such as [Ca2+] and/or hormones.

Initiation of an exercise bout is implemented here by increasing the rate of ATP hydrolysis in a stepwise manner [29] to a value proportional to the effective external work rate (WR + WRunload) applied by the cycle ergometer:

φATPADP(WR) = φATPADP, rest + γ1[WR + WRunload]

where ΦATP→ADP,rest is the resting muscle ATP turnover rate, γ1 is the conversion factor relating the effective external work rate to the units of ATP hydrolysis, and WRunload ≈ 25W is the WR equivalent of unloaded cycling. Once the desired WR has been selected, ATP utilization rate increases and parallel changes occur in several physiological variables.

The ATP demand is primarily met by the recruitment of motor units. At rest, there is a minimal level of contraction occurring throughout various areas of skeletal muscle tissue [41,42]. Due to the fact that not all muscle is engaged simultaneously over the period of time, we assume that in the resting state, the volume of active muscle is only a fraction of the total muscle volume. During exercise, the amount of muscle mass actively participating in muscular contraction is linearly related to the work rate [41,42]. Therefore, in our model, the active muscle tissue cells volume Vc is expressed in terms of the work rate (WR) as:

Vc(WR) = Vc, rest + γ2[WR + WRunload]

where γ2 is the slope ΔVc/Δ(WR+WRunload) and Vc,rest is the active muscle tissue cells volume at rest; γ2 can be different for different loading conditions. In contrast, the skeletal muscle blood flow response to a step change in work rate (WR) is expressed as [53]:

Q(t, WR) = Qrest + γ3[WR + WRunload][1 - exp-t]

where γ3 is the slope ΔQ(t = ∞)/Δ(WR+WRunload), τ is the time constant of response, and Qrest the resting skeletal muscle blood flow; τ can be different for different muscle conditions, while γ3 can be assumed constant, as the steady-state blood flow rate during exercise can be independent of the muscle condition.

To account for a tight coupling of energy demand-energy supply pathways that is known to occur in exercising muscle, the metabolic reaction fluxes were expressed in terms of the work rate (WR). Anticipating that the feedback controls by ADP, Pi and NADH (through cofactors CATP/CADP or CADP/CATP and CNADH/CNAD+ or CNAD+/CNADH) may not alone be enough to achieve the tight coupling of ATP supply-ATP demand systems during exercise, we chose to upregulate the effective enzyme activity for each reaction by multiplying each Vmax in the flux expressions by the relative metabolic rate (RMR):

RMR=MRrest+1η[WR+WRunload]MRrest MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaajaaycqWGsbGucqWGnbqtcqWGsbGucqGH9aqpkmaalaaajaaybaGaemyta0KaemOuaiLcdaWgaaqcbawaaiabdkhaYjabdwgaLjabdohaZjabdsha0bqabaqcaaMaey4kaSIcdaWcbaqcbawaaiabigdaXaqaaGGaciab=D7aObaakmaadmaajaaybaGaem4vaCLaemOuaiLaey4kaSIaem4vaCLaemOuaiLcdaWgaaqcbawaaiabdwha1jabd6gaUjabdYgaSjabd+gaVjabdggaHjabdsgaKbqabaaajaaycaGLBbGaayzxaaaabaGaemyta0KaemOuaiLcdaWgaaqcbawaaiabdkhaYjabdwgaLjabdohaZjabdsha0bqabaaaaaaa@58E1@

where η is the mechanical coupling efficiency [29,54] and MRrest the resting metabolic rate; η converts WR from the units of mechanical to metabolic watts. If no external work is performed, RMR = 1 and the Vmax values remain unchanged. To implement a feedforward control during exercise, the effective enzyme activities – characterized by the Vmax parameters- of the energy producing pathways are increased in proportion to the relative increase in metabolic rate [29,34,35,37]. This way, the metabolic reaction fluxes are implicitly expressed in terms of the ATP turnover rate through the variable WR. The model physiological parameters in Eqs. (6) – (9) are given in Table 1.

Table 1.

The values of model physiological parameters characterizing the moderate intensity exercise conditions (30–45% VO2 max, WR = 65W) for different loading states (if available)

Parameter Value Unit Equation Reference
Vc,rest, Vc,restLD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaqhaaWcbaGaee4yamMaeeilaWIaeeOCaiNaeeyzauMaee4CamNaeeiDaqhabaGaeeitaWKaeeiraqeaaaaa@3800@ 4.0 L 7 [42,78]
Vc,restUL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaqhaaWcbaGaee4yamMaeeilaWIaeeOCaiNaeeyzauMaee4CamNaeeiDaqhabaGaeeyvauLaeeitaWeaaaaa@3822@ 3.5 L 7 [21]
γ1, γ1LD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFZoWzdaqhaaWcbaGaeGymaedabaGaeeitaWKaeeiraqeaaaaa@31A5@, γ1UL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFZoWzdaqhaaWcbaGaeGymaedabaGaeeyvauLaeeitaWeaaaaa@31C7@ 2.25 mmol/(min × W) 6 [29]
γ2, γ2LD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFZoWzdaqhaaWcbaGaeGOmaidabaGaeeitaWKaeeiraqeaaaaa@31A7@ 0.0375 L/W 7 [42,78]
γ2UL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFZoWzdaqhaaWcbaGaeGOmaidabaGaeeyvauLaeeitaWeaaaaa@31C9@ 0.043 L/W 7 [21]
γ3, γ3LD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFZoWzdaqhaaWcbaGaeG4mamdabaGaeeitaWKaeeiraqeaaaaa@31A9@, γ3UL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFZoWzdaqhaaWcbaGaeG4mamdabaGaeeyvauLaeeitaWeaaaaa@31CB@ 0.0575 L/(min × W) 8 [29,70]
Qrest 0.9 L/min 8 [45]
τQ 0.35 min 8 [53]
τQLD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaemyuaefabaGaeeitaWKaeeiraqeaaaaa@31FE@ 0.25 min 8 [53]
τQUL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaemyuaefabaGaeeyvauLaeeitaWeaaaaa@3220@ 0.45 min 8 [79]
η 0.5 unitless 9 [54,71]
MRrest 20.6 W 9 [71]
WR 65.0 W 6, 7, 8, 9 [29]
WRunload 25.0 W 6, 7, 8, 9 [29]
RQ 0.785 unitless Vco2/VO2 [67,68]

Parameter estimation and model validation

The model kinetic parameters for a normal sedentary individual were obtained and the model was validated by comparing model simulation results with experimental data at (i) rest, (ii) during severe ischemia, and (iii) during moderate-intensity exercise. Most initial parameter estimates for the loaded and unloaded states were obtained from the literature. Parameter values were then tuned manually by comparing model simulated dynamic responses to moderate-intensity exercise with available experimental data. The model consists of a system of nonlinear ordinary differential and algebraic equations (Appendix A and B), which are solved numerically as an initial value problem with a well-developed FORTRAN implicit integrator DLSODES (Livermore Solver for Ordinary Differential Equations) [55].

Information on skeletal muscle metabolism in humans was gathered from various studies on sedentary healthy individuals [43,51,56-61]. Information corresponding to the chronically-loaded muscle was obtained from (i) intervention studies where physiological parameters were evaluated in sedentary subjects who took part in endurance-training programs [6,12,13,15,62] and (ii) related studies that compared sedentary and trained individuals [16,18,20]. In regards to the chronic unloading muscle, most available data was obtained from (i) bed rest studies ranging from 1–4 weeks [21,23,63] and (ii) detraining studies in athletes lasting 4–12 weeks [8,22,24,64]. Values for arterial and venous species concentrations and muscle blood flow were obtained from the femoral bed in human studies [12,43,65,66], while the values for intracellular species concentrations were obtained from muscle biopsies of the quadriceps [6,56,57]. Most substrate concentrations were the same at rest for all loading states with the exception of intramuscular triglyceride and glycogen concentrations and several metabolite concentrations in arterial blood. Tables 2 and 3 list arterial and intracellular concentrations, respectively, of all included species in each state. Blood-tissue partition coefficients were estimated from the blood-tissue exchange term (uptake-release rates). The coefficients for the nine species that are either taken up or released by skeletal muscle are displayed in Table 2.

Table 2.

Arterial species concentrations (mM) and blood-tissue partition coefficients (unitless) estimated from resting conditions for three different loading states.

Species Arterial Species Concentrations Blood-Tissue Partition Coefficients

Sedentary Loaded Unloaded Sedentary Loaded Unloaded
GLU 4.2 4.2 4.2 7.62 7.62 7.62
PYR 0.068 0.068 0.068 1.3 1.3 1.3
LAC 0.7 0.7 0.7 0.471 0.471 0.471
ALA 0.192 0.192 0.24 0.182 0.182 0.219
TGL 0.99 0.86 1.26 0.0667 0.0492 0.0679
GLC 0.06 0.06 0.04 1.02 1.02 0.7
FFA 0.59 0.59 0.43 0.867 0.867 0.587
CO2 21.7 21.7 21.7 1.02 1.02 1.02
O2 8.0 8.0 8.0 1.65 1.65 1.65

The species concentrations are obtained from a variety literature sources on skeletal muscle metabolism (for references, see the text in Method section). The partition coefficients σ is calculated from the formula Cb,j = Cv,j = σj Cc,j, where Cb,j, Cv,j and Cc,j are the blood, venous and tissue cells species concentrations

Table 3.

Muscle tissue cells species concentrations at rest for the three different loading states (concentrations are in the units of mM).

Species Sedentary Loaded Unloaded
GLU 0.525 0.525 0.525
GLY 95.0 110.0 110.0
G6P 0.253 0.253 0.253
GA3P 0.08 0.08 0.08
BPG 0.08 0.08 0.08
PYR 0.0475 0.0475 0.0475
LAC 1.75 1.75 1.75
ALA 1.3 1.3 1.3
TGL 14.8 17.4 18.5
GLC 0.062 0.062 0.062
FFA 0.57 0.57 0.57
FAC 0.00348 0.00348 0.00348
ACoA 0.00223 0.00223 0.00223
CIT 0.103 0.103 0.103
AKG 0.0125 0.0125 0.0125
SCoA 0.123 0.123 0.123
SUC 0.095 0.095 0.095
MAL 0.0975 0.0975 0.0975
OXA 0.003 0.003 0.003
CO2 23.6 23.6 23.6
O2 3.0 3.0 3.0
PCr 20.0 20.0 20.0
Cr 10.0 10.0 10.0
Pi 2.7 2.7 2.7
CoA 0.0255 0.0255 0.0255
NADH 0.05 0.05 0.05
NAD+ 0.45 0.45 0.45
ATP 6.3 6.3 6.3
ADP (free) 0.02 0.02 0.02
AMP (free) 6.0E-5 6.0E-5 6.0E-5

The species concentrations are obtained from a variety literature sources on skeletal muscle metabolism (for references, see the text in Method section)

Flux balance analysis is done to determine the reaction flux rates at resting steady states. In the first step, we estimated the relative contribution of carbohydrates and fats as fuels from the measurements of respiratory quotient (RQ) across the quadriceps muscle at rest [67,68]. Then, we determined the rate of CO2 production at rest from the known values of muscle VO2 at rest in combination with resting RQ value. Assuming carbohydrates (CHO, RQCHO = 1.0) and fats (FFA, RQFFA = 0.7) are the only fuels, we calculated the relative contributions from CHO and FFA towards the muscle CO2 production under resting, steady-state conditions. Then, we determined the reaction flux rates through the oxidative pathways of both CHO and FFA using appropriate stoichiometric relationships. The information derived from tracer studies was used to determine the flux rates of the forward- and reverse-contributions of reversible reactions such as the lactate dehydrogenase system and glycogen breakdown and synthesis systems [13]. The estimated reaction flux rates are displayed in Table 4.

Table 4.

Metabolic reaction fluxes (mmol/min) estimated under resting steady-state conditions from flux balance analysis and reaction maximal velocities (mmol/min) estimated under resting steady-state conditions from reaction fluxes for three different loading states.

Reaction Fluxes Resting Flux Values Maximal Velocities Sedentary Loading Unloading
φGLU→G6P 0.182 VGLY→G6P 0.46 0.557 0.557
φG6P→GLY 0.258 VG6P→GLY 2.58 3.42 2.58
φGLY→G6P 0.258 VGLY→G6P 1.72 1.72 2.08
φG6P→GA3P 0.182 VG6P→GA3P 1.63 1.45 1.91
φGA3P→BPG 0.363 VGA3P→BPG 48.0 48.0 48.0
φBPG→PYR 0.363 VBPG→PYR 25.4 25.4 25.4
φPYR→LAC 0.294 VPYR→LAC 8.81 6.86 8.81
φLAC→PYR 0.182 VLAC→PYR 1.09 0.85 1.09
φPYR→ALA 0.04 VPYR→ALA 0.12 0.12 0.16
φPYR→ACoA 0.217 VPYR→ACoA 15.2 15.2 15.2
φTGL→GLC 0.13 VTGL→GLC 0.65 0.823 0.65
φGLC→TGL 0.127 VGLC→TGL 1.78 2.31 1.78
φFFA→FAC 0.095 VFFA→FAC 1.33 1.73 1.06
φFAC→ACoA 0.095 VFAC→ACoA 0.951 1.2 0.768
φACoA→CIT 0.978 VACoA→CIT 6.84 9.54 5.71
φCIT→AKG 0.978 VCIT→AKG 9.78 14.2 8.22
φAKG→SCoA 0.978 VAKG→SCoA 13.7 19.1 11.4
φSCoA→SUC 0.978 VSCoA→SUC 13.7 19.1 11.4
φSUC→MAL 0.978 VSUC→MAL 5.87 8.8 4.89
φMAL→OXA 0.978 VMAL→OXA 5.87 8.8 4.89
φO2→H2O 2.75 VO2→H2O 24.6 35.2 20.3
φPCR→CR 667.0 VPCR→CR 4000.0 4000.0 4000.0
φCR→PCR 667.0 VCR→PCR 4000.0 4000.0 4000.0
φATP→ADP 16.0 VATP→ADP 16.2 16.2 16.2
φAMP→ADP 50.0 VAMP→ADP 250.0 250.0 250.0
φADP→AMP 50.0 VADP→AMP 250.0 250.0 250.0

The maximal velocities differ between different muscle states due to different Km values

The kinetic parameters (Vmax and Km) were obtained from information available on the specific enzyme kinetics. For enzymes catalyzing oxidative phosphorylation, hexokinase, and ATP hydrolysis, the Km's were set to values much smaller than the corresponding intracellular reactants concentrations because of their high affinity for the respective reactants [9,30,34]. The remaining Km's were assumed to have values very close to those of the corresponding reactants [30]. After setting the Km values, the Vmax values were estimated from known flux rates from flux balance analysis. Fine tuning of several kinetic parameters was needed by comparing model responses with experimental data during different physiological conditions, particularly during severe muscle ischemia [58,61] and moderate-intensity exercise [12,13,43,45,60,65,69] (e.g., see Figures 3, 4, 5, 6). Since the number of unknown model parameters was too large, without enough bound/physiological/thermodynamic constraints, a formal parameter estimation algorithm would provide non-unique estimations. Therefore, the model parameters were not estimated through optimization. Instead, only those parameters, which are directly linked to the measured output variables were estimated manually through an ad hoc trial-and-error method. For example, the Km values associated with the flux expression of the hexokinase reaction would directly influence the concentrations of glucose (GLU) and glucose-6-phosphate (G6P), and therefore for fitting the model to the data on [GLU] and [G6P], those Km parameters need to be tuned first. Though a formal parameter sensitivity analysis would be helpful in identifying the most or least sensitive model parameters for estimation, it needs special attention, as the model involve many unknown parameters, and therefore it is beyond the scope of the present study. Tables 4 and 5 list the maximal reaction velocities (Vmax) and Michaelis-Menten constants (Km) for each reaction under the three muscle conditioned states.

Figure 3.

Figure 3

Dynamic responses of ATP and NADH concentrations during a 10-min moderate intensity exercise period (WR = 65W) of a sedentary individual. The left y-axis corresponds to changes in [ATP] while the right y-axis indicates the changes in [NADH]. Steady state responses are present from time -5 min to time 0 min when the step change in work rate (WR) is initiated. The solid and dashed lines represent the model simulation results with the symbols representing experimental data points [mean ± SD] [60,69]. [ATP] remains fairly constant while [NADH] drops 40% during exercise.

Figure 4.

Figure 4

Simulated dynamic responses of oxygen uptake and carbon dioxide release during a 10-min moderate-intensity exercise bout (WR = 65W) of a sedentary individual. Positive values correspond to O2 uptake (VO2 = Q(Ca,O2 - σO2Cc,O2)) while negative values correspond to CO2 release (VCO2 = Q(Ca,CO2 - σCO2Cc,CO2)) from skeletal muscle. The time constant of O2 uptake (τVO2) is about 0.5 min and that of CO2 release (τVCO2) is about 0.6 min. The respiratory quotient (RQ = VCO2/VO2) increases from 0.785 at rest to 0.832 during exercise.

Figure 5.

Figure 5

Dynamic concentration profiles of phosphocreatine (PCr) and inorganic phosphate (Pi) during a 10-min moderate-intensity exercise period (WR = 65W) of a sedentary individual. The steady state responses are present from time -5 min to time 0 min when the step change in work rate (WR) is initiated. The solid and dashed lines represent the model simulation results with the symbols representing experimental data points [mean ± SD] [65]. The time constants of both [PCr] drop and [Pi] rise are approximately equal (τPCr ≈ τPi ≈ 0.5 min). The dynamics of [PCr] match very well with the dynamics of muscle VO2 [72-74].

Figure 6.

Figure 6

Simulated dynamic responses of glucose uptake and lactate release during a 10-min moderate-intensity exercise bout (WR = 65W) of a sedentary person. Positive values correspond to GLU uptake while negative values correspond to LAC release from skeletal muscle. The solid and dashed lines signify the model simulation results with the symbols representing experimental data points [mean ± SD] [12,13,43,45]. Both glucose uptake and lactate release have the biphasic behavior/transients.

Table 5.

Phenomenological Michaelis-Menten kinetic constants for chemical species and energy controller ratios in 26 reactions for three different loading states (SED, LD, UL). These are estimated as discussed in the Method section

Glucose Utilization: Glycogen Synthesis:
GLU + ATP → G6P + ADP G6P + ATP → GLY + ADP 2 + Pi
SED LD UL SED LD UL
KGLU 0.07 0.07 0.14 KG6P 0.253 0.843 0.253
KG6P 0.253 0.084 0.253 KGLY 95 367 110
KATPADP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGubavcqqGqbauaeaacqqGbbqqcqqGebarcqqGqbauaaaabeaaaaa@34A5@ 315 315 315 KPi 2.7 9 2.7
KATPADP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGubavcqqGqbauaeaacqqGbbqqcqqGebarcqqGqbauaaaabeaaaaa@34A5@ 315 315 315
Glycogen Utilization: Glucose 6-Phosphate Breakdown:
GLY + Pi → G6P G6P + ATP → 2 GA3P + ADP
SED LD UL SED LD UL
KGLY 95 110 132 KG6P 0.253 0.169 0.38
KPi 2.7 2.7 3.24 KGA3P 0.08 0.053 0.12
KG6P 0.253 0.253 0.304 KAMPATP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGnbqtcqqGqbauaeaacqqGbbqqcqqGubavcqqGqbauaaaabeaaaaa@34B7@ 1.9e – 5 1.9e – 5 1.9e – 5
KAMPATP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGnbqtcqqGqbauaeaacqqGbbqqcqqGubavcqqGqbauaaaabeaaaaa@34B7@ 3.2e – 6 3.2e – 6 3.2e – 6
Glyceraldehyde 3-Phosphate Breakdown: Pyruvate Production:
GA3P + NAD+ + Pi → BPG + NADH BPG + 2 ADP → PYR + 2 ATP
SED LD UL SED LD UL
KGA3P 0.8 0.8 0.8 KBPG 0.4 0.4 0.4
KPi 27 27 27 KPYR 0.238 0.238 0.238
KBPG 0.8 0.8 0.8 KADPATP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGebarcqqGqbauaeaacqqGbbqqcqqGubavcqqGqbauaaaabeaaaaa@34A5@ 0.029 0.029 0.029
KNAD+NADH MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGobGtcqqGbbqqcqqGebarcqqGRaWkaeaacqqGobGtcqqGbbqqcqqGebarcqqGibasaaaabeaaaaa@3671@ 0.09 0.09 0.09
Pyruvate Reduction: Lactate Oxidation:
PYR + NADH → LAC + NAD+ LAC + NAD+ → PYR + NADH
SED LD UL SED LD UL
KPYR 0.0475 0.016 0.0475 KLAC 1.75 0.583 1.75
KLAC 1.75 0.583 1.75 KPYR 0.0475 0.016 0.0475
KNADHNAD+ MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGobGtcqqGbbqqcqqGebarcqqGibasaeaacqqGobGtcqqGbbqqcqqGebarcqqGRaWkaaaabeaaaaa@3671@ 1 1 1 KNAD+NADH MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGobGtcqqGbbqqcqqGebarcqqGRaWkaeaacqqGobGtcqqGbbqqcqqGebarcqqGibasaaaabeaaaaa@3671@ 9 9 9
Alanine Production: Lipolysis:
PYR → ALA TGL → GLC + 3 FFA
SED LD UL SED LD UL
KPYR 0.0475 0.0475 0.095 KTGL 14.8 52.2 18.5
KALA 1.3 1.3 2.6 KGLC 0.062 0.186 0.062
KFFA 0.57 1.71 0.57
Pyruvate Oxidation: Triglyceride Synthesis:
PYR + CoA + NAD+ → ACoA + NADH + CO2 GLC + 3 FFA + 7 ATP → TGL 7 + ADP + 7 Pi
SED LD UL SED LD UL
KPYR 0.0475 0.0475 0.0475 KGLC 0.062 0.083 0.062
KCoA 0.0255 0.0255 0.0255 KFFA 0.57 0.76 0.57
KACoA 2.2e – 3 2.2e – 3 2.2e – 3 KTGL 14.8 23.2 18.5
KCO2 23.6 23.6 23.6 KPi 2.7 3.6 2.7
KNAD+NADH MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGobGtcqqGbbqqcqqGebarcqqGRaWkaeaacqqGobGtcqqGbbqqcqqGebarcqqGibasaaaabeaaaaa@3671@ 81 81 81 KATPADP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGubavcqqGqbauaeaacqqGbbqqcqqGebarcqqGqbauaaaabeaaaaa@34A5@ 315 315 315
Free Fatty Acid Utilization: Fatty Acyl-CoA Oxidation:
FFA + CoA + 2 ATP → FAC + 2ADP + 2Pi FAC + 7 CoA + (35/3) NAD+ → 8 ACoA + (35/3) NADH
SED LD UL SED LD UL
KFFA 0.57 0.76 0.43 KFAC 3.5e – 3 4.35e – 3 2.78e – 3
KCoA 0.026 0.034 0.019 KCoA 0.0255 0.0319 0.02
KFAC 3.5e – 3 4.6e – 3 2.6e – 3 KACoA 2.2e – 3 2.8e – 3 1.8e – 3
KPi 2.7 3.6 2 KNAD+NADH MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGobGtcqqGbbqqcqqGebarcqqGRaWkaeaacqqGobGtcqqGbbqqcqqGebarcqqGibasaaaabeaaaaa@3671@ 9 9 9
KATPADP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGubavcqqGqbauaeaacqqGbbqqcqqGebarcqqGqbauaaaabeaaaaa@34A5@ 315 315 315
Citrate Production: α-Ketoglutarate Production:
ACoA + OXA → CIT + CoA CIT + NAD+ → AKG + NADH + CO2
SED LD UL SED LD UL
KACoA 2.2e – 3 3.2e – 3 1.8e – 3 KCIT 0.103 0.412 0.0824
KOXA 3.0e – 3 4.3e – 3 2.4e – 3 KAKG 0.0125 0.05 0.0125
KCIT 0.103 0.147 0.082 KCO2 23.6 94.4 23.6
KCoA 0.0255 0.0364 0.02 KNAD+NADH MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGobGtcqqGbbqqcqqGebarcqqGRaWkaeaacqqGobGtcqqGbbqqcqqGebarcqqGibasaaaabeaaaaa@3671@ 9 9 9
Succinyl-CoA Production: Succinate Formation:
AKG + CoA + NAD+ → SCoA + NADH + CO2 SCoA +ADP + Pi → SUC + CoA + ATP
SED LD UL SED LD UL
KAKG 0.0125 0.0179 0.01 KSCoA 0.123 0.176 0.0984
KCoA 0.0255 0.0364 0.02 KPi 2.7 3.9 2.2
KSCoA 0.123 0.176 0.0984 KSUC 0.095 0.136 0.076
KCO2 23.6 33.7 18.9 KCoA 0.0255 0.0364 0.02
KNAD+NADH MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGobGtcqqGbbqqcqqGebarcqqGRaWkaeaacqqGobGtcqqGbbqqcqqGebarcqqGibasaaaabeaaaaa@3671@ 9 9 9 KADPATP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGebarcqqGqbauaeaacqqGbbqqcqqGubavcqqGqbauaaaabeaaaaa@34A5@ 3.2e – 3 3.2e – 3 3.2e – 3
Malate Production: Oxaloacetate Production:
SUC + (2/3) NAD+ → MAL + (2/3) NADH MAL + NAD+ → OXA + NADH
SED LD UL SED LD UL
KSUC 0.095 0.238 0.0475 KMAL 0.0975 0.244 0.0488
KMAL 0.0975 0.244 0.0488 KOXA 3.0e – 3 7.5e – 3 1.5e – 3
KNAD+NADH MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGobGtcqqGbbqqcqqGebarcqqGRaWkaeaacqqGobGtcqqGbbqqcqqGebarcqqGibasaaaabeaaaaa@3671@ 9 9 9 KNAD+NADH MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGobGtcqqGbbqqcqqGebarcqqGRaWkaeaacqqGobGtcqqGbbqqcqqGebarcqqGibasaaaabeaaaaa@3671@ 9 9 9
Phosphocreatine Breakdown: Phosphocreatine Synthesis:
PCR + ADP → CR + ATP CR + ATP → PCR + ADP
SED LD UL SED LD UL
KPCR 20 20 20 KCR 10 10 10
KCR 10 10 10 KPCR 20 20 20
KADPATP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGebarcqqGqbauaeaacqqGbbqqcqqGubavcqqGqbauaaaabeaaaaa@34A5@ 3.2e – 3 3.2e – 3 3.2e – 3 KATPADP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGubavcqqGqbauaeaacqqGbbqqcqqGebarcqqGqbauaaaabeaaaaa@34A5@ 315 315 315
Oxygen Utilization: ATP Hydrolysis
O2 + 5.63 ADP + 5.63 Pi + 1.88 NADH → 2 H2O + 5.63 ATP + 1.88 NAD+ ATP → ADP + Pi
SED LD UL SED LD UL
KO2 0.01 0.01 0.01 KATP 0.063 0.063 0.063
KNADH 0.07 0.09 0.06
KPi 3.8 4.9 3.2
KNAD+ MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaGaeeOta4KaeeyqaeKaeeiraq0aaWbaaWqabeaacqGHRaWkaaaaleqaaaaa@324D@ 0.63 0.81 0.54
KADPATP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaWaaSaaaeaacqqGbbqqcqqGebarcqqGqbauaeaacqqGbbqqcqqGubavcqqGqbauaaaabeaaaaa@34A5@ 6.3e – 3 6.3e – 3 6.3e – 3
AMP Utilization: AMP Production:
AMP + ATP → 2 ADP 2 ADP → AMP + ATP
SED LD UL SED LD UL
KAMP 6e – 5 6e – 5 6e – 5 KADP 0.02 0.02 0.02
KATP 6.3 6.3 6.3 KAMP 6e – 5 6e – 5 6e – 5
KADP 0.02 0.02 0.02 KATP 6.3 6.3 6.3

The conversion factor relating work rate to ATP turnover rate is derived from known relationships between muscle VO2 and work rate [29]. The relationship between muscle volume recruitment and work rate was determined from MRI studies quantifying the amount of active muscle for different work rates [41,42]. Parameters characterizing the dynamics of blood flow response to exercise were estimated from known relationships between muscle blood flow and work rate [29,70] and studies using Doppler ultrasound to measure the femoral artery blood velocity [53]. The steady-state blood flow for a particular work rate is found using the known relationship between muscle blood flow and work rate [29,70]. Finally, the relative metabolic rate term that links processes of ATP synthesis to ATP hydrolysis is a function of mechanical efficiency and resting metabolic rate. The mechanical efficiency, which converts external work into units of metabolic watts, is determined from studies that measure the mechanical work output as a result of free energy change through ATP hydrolysis [54,71].

To differentiate between different loading states, parameter values characterizing these states were used in simulations, namely the maximal reaction velocities (Vmax) of the enzymes and time constant characterizing the blood flow response. These parameters are directly linked to adaptations occurring as a result of either chronic loading or unloading. Indeed, in the model representing loading, significant modifications were made to the Vmax values of the oxidative enzymes according to relative percent changes measured experimentally. This change reflects the considerable increases in both mitochondrial size and density within the tissue [10]. Also, the time constant for blood flow (τQ) was reduced in the loading model to account for the increase in muscle capillarization [53]; τQ in the unloading model was accordingly increased to reflect the presence of fewer capillaries perfusing muscle fibers [8,63]. In regards to the unloading model, experimental data shows that more emphasis is placed on carbohydrate metabolism for ATP production, in particular glycogenolysis. Therefore, the Vmax values for glycogen phosphorylase and glucose phosphorylation were increased with accompanying decreases in oxidative enzymes' maximal reaction velocities [22,23].

Results

We first compared computer-simulated responses with experimental data obtained in healthy individuals during a 10-min moderate-intensity exercise bout (30–45% VO2 max, WR = 65W) on a cycle ergometer. Then, the steady-state and dynamic responses of individuals who have under-gone chronic interventions involving marked enhancements (loading) or reductions (unloading) in physical activity to a step change in ATP turnover rate, equivalent to the same change in work rate (WR = 65W), were compared to those obtained in healthy sedentary subjects. From these results, we determined quantitatively the effects of loading and unloading adaptations on fuel preference during submaximal exercise.

Dynamic responses to submaximal exercise in sedentary state

A moderate-intensity exercise bout (30–45% VO2 max) for a normal, sedentary individual was simulated for 10 min by inducing changes in ATP turnover rate and other physiological variables equivalent to a step increase in work rate WR from 0 to 65 W. Active muscle mass increased instantaneously from 4 to 7.5 kg ww (Eq. 7), while muscle blood flow increased exponentially (τQ ≈ 0.35 min) from 0.9 to 6.0 L/min (Eq. 8). The rates of ATP production and utilization were closely matched, as the ATP concentration was stable throughout the exercise bout. In contrast, exercise caused a 40% drop in NADH concentration, from 0.05 to 0.03 mM [60,69]; this decline occurred in an exponential fashion, with the new steady-state in [NADH] reaching within 1 min of exercise onset, as depicted in Figure 3.

Model-simulated muscle oxygen uptake (VO2 = Q(Ca,O2 – σO2Cc,O2)) increased exponentially (τVO2 ≈ 0.5 min) from 2.75 mmol/min at rest to 36.5 mmol/min during exercise while muscle CO2 release (VCO2 = Q(Ca,CO2 - σCO2Cc,CO2)) increased slightly slower (τVCO2 ≈ 0.6 min) from 2.16 to 30.4 mmol/min, as depicted in Figure 4. The respiratory quotient (RQ = VCO2/VO2) increased from 0.785 at rest to 0.832 during 10-min moderate-intensity exercise bout. The [PCr] dynamic response closely mirrored that of VO2 [72-74] decreasing about 10% from its resting value of 20 mM to about 16 mM during exercise with a τPCr ≈ 0.5 min, as depicted in Figure 5. Therefore, the model supports one of the key hypotheses in muscle bioenergetics that the muscle [PCr] and VO2 dynamics match very well during moderate-intensity exercise [72-74]. The model also predicts linear relationships between the steady-state [PCr] and WR and steady-state VO2 and WR during submaximal exercise bouts (0 ≤ WR ≤ 100 Watts), indicating that the model successfully mimic the linear relationship between [PCR] and VO2 at steady-state (not shown), seen experimentally [75]. The concentration of Pi (inorganic phosphate) increased from 2.7 mmol/kg ww at rest to about 4.6 mmol/kg ww during exercise with a τPi equivalent to τPCr (Fig 5).

Muscle glucose uptake increased from 0.18 to 1.76 mmol/min within the first 30 seconds of exercise onset, and then decreased to its steady-state value of 1.38 mmol/min, as shown in Figure 6. The net glycogen breakdown increased rapidly from 0.0 to 0.15 mmol/min, resulting in a linear decrease in glycogen concentration from 95 to 93.5 mM during 10-min moderate-intensity exercise bout. Concentrations of both glucose 6-phosphate and pyruvate increased ~ 35% from their resting values in an exponential manner (τ ≈ 0.85 min). The lactate release from muscle increased abruptly from 0.11 to 0.63 mmol/min before reaching its steady-state value of 0.32 mmol/min, as shown in Figure 6. Both glucose uptake and lactate release were seen to have a biphasic behavior.

During 10-min exercise bout, the concentration of acetyl-CoA increased 50% from its resting value of 2.23 μM, with the carbohydrates contributing a larger portion toward the increased acetyl-CoA production, as shown in Figure 7. At rest, approximately 22% of the acetyl-CoA produced came from pyruvate oxidation, with the remaining 78% coming from fat oxidation. However, during exercise, the pyruvate oxidation contributed about 38% towards total acetyl-CoA production, with the fats contributing about 62%. This causes an increase in the muscle respiratory quotient (RQ) from 0.785 at rest to 0.832 at the end of 10-min exercise, though not significantly, but within the experimental range for moderate-intensity exercise [67,68].

Figure 7.

Figure 7

Simulated relative contributions from carbohydrates and fats towards the steady-state acetyl-CoA production at rest and during a 10-min moderate-intensity exercise bout (WR = 65W) of a sedentary individual.

Dynamic responses to submaximal exercise after chronic loading or unloading

The dynamic responses of selected metabolite concentrations and reaction fluxes to 10 min of moderate-intensity, constant work rate exercise (WR = 65W) were compared for the chronic loading (LD) and unloading (UL) states. The simulations previously described for the sedentary (SED) state served as the control state. The pattern of muscle mass recruited at the onset of exercise was assumed the same in all three groups (Eq. 7, Table 1). Muscle blood flow for LD and UL states was increased in an exponential manner (input) towards the same steady-state value, with LD reaching it faster than UL (τQLD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaemyuaefabaGaeeitaWKaeeiraqeaaaaa@31FE@ ≈ 0.25 min vs. τQUL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaemyuaefabaGaeeyvauLaeeitaWeaaaaa@3220@ ≈ 0.45 min; Eq. 8, Table 1), as shown in Figure 8. Similar transient profiles were predicted from model simulations for muscle oxygen uptake (VO2), with differences between LD and UL states occurring only in the transient phase, as shown in Figure 9. In the first minute, the muscle VO2 for a LD individual reached steady state sooner than a UL individual (τVO2LD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeOvayLaee4ta8KaeeOmaidabaGaeeitaWKaeeiraqeaaaaa@3416@ ≈ 0.4 min vs. τVO2UL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeOvayLaee4ta8KaeeOmaidabaGaeeyvauLaeeitaWeaaaaa@3438@ ≈ 0.55 min). As a result of this faster delivery of arterial O2 to the tissue in LD muscles, the LD intramuscular O2 stores are spared, and the increase in VO2(LD) is more gradual after the first minute of exercise onset until a new steady-state is reached. In UL muscles, with a larger reliance on tissue O2 during the initial minute of exercise, VO2(UL) increases more rapidly from minute one until the new steady-state is reached. However, in both states, the muscle VO2 dynamics was slower than the muscle blood flow dynamics, which indicates that O2 delivery to the tissue was limited due to the availability of stored O2 in the tissue.

Figure 8.

Figure 8

Skeletal muscle blood flow responses to a moderate-intensity exercise bout (WR = 65W) for three different muscle states. The range of the x-axis is reduced in order to amplify the transient changes between the chronically-loaded and unloaded states. The time constant of blood flow (τQ) for loaded, sedentary and unloaded muscles was set as 0.25, 0.35 and 0.45 min, respectively (Table 1).

Figure 9.

Figure 9

Simulated dynamic oxygen uptake responses during a 10-min moderate-intensity exercise bout (WR = 65W) for sedentary and chronically-loaded/unloaded individuals. The range of the x-axis is reduced in order to amplify the transient changes between loading states. The vertical bar located at time = 1 min divides the response into two phases. The initial muscle VO2 responses at the onset of exercise (phase I) are largely functions of the blood flow response. In phase II, the responses are dependent on the intramuscular oxygen stores. The time constant of muscle VO2 VO2) for loaded, sedentary and unloaded muscles was about 0.4, 0.5 and 0.56 min, respectively.

At exercise onset, the phosphorylation ratio [ADP]/[ATP] increases exponentially, while the creatine ratio [PCr]/[Cr] decreases exponentially with the similar time constant (τADP/ATPLD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeyqaeKaeeiraqKaeeiuaaLaee4la8IaeeyqaeKaeeivaqLaeeiuaafabaGaeeitaWKaeeiraqeaaaaa@3856@τPCr/CrLD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeiuaaLaee4qamKaeeOCaiNaee4la8Iaee4qamKaeeOCaihabaGaeeitaWKaeeiraqeaaaaa@37CF@ ≈ 0.3 min and τADP/ATPUL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeyqaeKaeeiraqKaeeiuaaLaee4la8IaeeyqaeKaeeivaqLaeeiuaafabaGaeeyvauLaeeitaWeaaaaa@3878@τPCr/CrUL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeiuaaLaee4qamKaeeOCaiNaee4la8Iaee4qamKaeeOCaihabaGaeeyvauLaeeitaWeaaaaa@37F1@ ≈ 0.45 min), as shown in Figures 10 and 11. So the model supports the hypothesis that the dynamics of [ADP]/[ATP] and [PCr]/[Cr] ratios match very well during moderate-intensity exercise [74], even in LD and UL muscles. The steady-state [ADP]/[ATP] ratio during exercise for the UL muscle was about 7% higher than that for LD muscle (Fig 10), suggesting a larger uncoupling between ATP utilization and ATP formation in the UL muscle. A 7% greater decline in steady-state [PCr]/[Cr] ratio occurred during exercise in the UL muscles compared with the LD muscles as a result of increased reliance on PCr (Fig 11).

Figure 10.

Figure 10

Simulated dynamic responses of the phosphorylation ratio [ADP]/[ATP] during a 10-min moderate-intensity exercise period (WR = 65W) for sedentary and chronically-loaded/unloaded individuals. The steady state responses are present from time -5 min to time 0 min when the step change in work rate (WR) is initiated.

Figure 11.

Figure 11

Simulated dynamic responses of the creatine ratio [PCr]/[Cr] during a 10-min moderate-intensity exercise period (WR = 65W) for sedentary and chronically-loaded/unloaded individuals. The dynamics of [PCr]/[Cr] ratio matches well with the dynamics of [ADP]/[ATP] ratio, with τADP/ATPLD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeyqaeKaeeiraqKaeeiuaaLaee4la8IaeeyqaeKaeeivaqLaeeiuaafabaGaeeitaWKaeeiraqeaaaaa@3856@τPCr/CrLD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeiuaaLaee4qamKaeeOCaiNaee4la8Iaee4qamKaeeOCaihabaGaeeitaWKaeeiraqeaaaaa@37CF@ ≈ 0.3 min, τADP/ATPSED MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeyqaeKaeeiraqKaeeiuaaLaee4la8IaeeyqaeKaeeivaqLaeeiuaafabaGaee4uamLaeeyrauKaeeiraqeaaaaa@3975@τPCr/CrSED MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeiuaaLaee4qamKaeeOCaiNaee4la8Iaee4qamKaeeOCaihabaGaee4uamLaeeyrauKaeeiraqeaaaaa@38EE@ ≈ 0.35 min, and τADP/ATPUL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeyqaeKaeeiraqKaeeiuaaLaee4la8IaeeyqaeKaeeivaqLaeeiuaafabaGaeeyvauLaeeitaWeaaaaa@3878@τPCr/CrUL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeiuaaLaee4qamKaeeOCaiNaee4la8Iaee4qamKaeeOCaihabaGaeeyvauLaeeitaWeaaaaa@37F1@ ≈ 0.45 min.

Figure 12 shows the net glycogen breakdown rates for the three conditioned muscle states during a 10-min moderate-intensity exercise bout. In each case, the glycogenolysis initially increases rapidly before slowly decreasing towards a new steady-state level. It is seen that the net glycogen breakdown rate for UL muscle increases from 0 at rest to 0.18 mM/min over the 10-min exercise period, while in the LD muscle, the response shows an increase from 0 to 0.13 mM/min. Thus, the chronically loaded muscle utilizes less glycogen for a submaximal exercise bout.

Figure 12.

Figure 12

Simulated dynamic responses of the net glycogen breakdown in muscle tissue during a 10-min moderate-intensity exercise period (WR = 65W) for sedentary and chronically-loaded/unloaded individuals. The steady state responses are present from time -5 min to time 0 min when the step change in work rate (WR) is initiated.

The increased reliance on glycogen for the unloading state results in a 10% higher rate of glycolysis during moderate-intensity exercise compared with the loading state. This difference ultimately leads to higher concentrations of glycolytic intermediates such as glucose 6-phosphate and pyruvate for the unloading state. Since there were no differences in the redox ratio between conditioned states during exercise, the higher rates of net lactate formation seen (Fig 13) for chronically-unloaded compared with the loaded muscle is mainly due to the increase in pyruvate production from glycolysis during exercise, similar to what has been seen experimentally [65].

Figure 13.

Figure 13

Simulated dynamic responses of the net lactate formation in muscle tissue during a 10-min moderate-intensity exercise period (WR = 65W) for sedentary and chronically-loaded/unloaded individuals. The net lactate formation has tri-phasic behavior.

The lactate production rate in muscle tissue during exercise was seen to have a triphasic behavior. At the onset of exercise, the production of lactate increases rapidly to levels around 5-fold higher than that at rest, followed by a swift drop to resting levels. This transient response occurs within the first minute, and is the same for all conditioned states, as depicted in Figure 13. After that, there is an exponential increase, with the new steady-state values reached by 3 min. The early large production of lactate is consistent with the previous experimental finding by Connett et al. [44]. The steady-state net lactate production in the chronically unloaded muscle is about 20% higher when compared with the loaded muscle. The dynamic responses for net lactate release from muscle tissue during exercise for loading and unloading states are displayed in Figure 14. Initially, the net lactate release (negative of the shown flux) increased rapidly, with largest changes seen in the loading state (0.11 to 0.68 mM/min). In about 45 seconds, the net lactate release increased exponentially in all conditioned states to its new steady-state levels, which were reached in 4 min. The difference in steady-state lactate release values between chronically unloaded and loaded muscles was around 17%, as depicted in Figure 14.

Figure 14.

Figure 14

Simulated dynamic responses of the net lactate release from muscle tissue during a 10-min moderate-intensity exercise period (WR = 65W) for sedentary and chronically-loaded/unloaded individuals. Negative values correspond to a net lactate release from skeletal muscle which has bi-phasic behavior.

The rate of free fatty acid uptake increased exponentially during exercise, with τFFALD MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeOrayKaeeOrayKaeeyqaeeabaGaeeitaWKaeeiraqeaaaaa@3402@ = 0.3 min and τFFAUL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFepaDdaqhaaWcbaGaeeOrayKaeeOrayKaeeyqaeeabaGaeeyvauLaeeitaWeaaaaa@3424@ = 0.4 min. The chronically loaded muscle had a 7% higher rate of free fatty acid uptake compared to the unloaded muscle. The steady-state rates of acetyl-CoA production during exercise were similar in all three muscle conditions but the relative contributions differed from carbohydrates and fats. Figure 15 shows the relative contribution towards acetyl-CoA production from carbohydrate and fat oxidations during exercise in sedentary vs. chronically loaded/unloaded muscle. It is seen that carbohydrates have a larger contribution to the formation of acetyl-CoA in unloaded muscle (40% vs. 36%), while fats contribution is higher in chronically loaded muscle (64% vs. 60%). Both chronically loaded and -unloaded muscles at rest have similar tissue respiratory quotients (RQ) of 0.785. However, during exercise, the RQ for loaded muscle rises to 0.827, while the RQ for unloaded muscle increases to 0.836.

Figure 15.

Figure 15

Simulated relative contributions from carbohydrates and fats towards the steady-state acetyl-CoA production during a 10-min moderate-intensity exercise period (WR = 65W) for sedentary and chronically-loaded/unloaded individuals.

Discussion

In this paper, we successfully extended a previously developed mathematical model of skeletal muscle metabolism [28,29] by adding necessary biochemical components that are altered after periods of chronic loading or unloading to quantify some of the underlying key mechanisms associated with the metabolic responses to constant work rate, moderate-intensity exercise in these loading states. The model was first validated with published experimental data obtained from quadriceps muscle under conditions of moderate-intensity exercise in sedentary individuals. Once validated, the model was used to simulate and predict metabolic responses to moderate-intensity exercise in contracting muscle of individuals who have been subjected to a period of chronic loading or unloading.

Parallel activation of metabolic pathways during exercise

We conducted extensive computer simulations using this model of skeletal muscle metabolism in response to changes in metabolic rate (simulating work rate changes in the cycle ergometer) to predict changes in metabolite concentrations and reaction flux rates during increased metabolic demand. The aim of these simulations has been to investigate various mechanisms of respiratory control to gain understanding on how the cell adjusts its metabolic machinery and processes to activate enhanced delivery of reducing equivalents (NADH) to the mitochondria for a sudden increase in the rate of ATP synthesis. During voluntary muscle contraction, cellular metabolism is altered and oxygen and fuel delivery is stimulated through adjustments in convection/diffusion reaction processes by the ventilatory, cardiovascular, and muscular systems. Since the current in vivo techniques, such as indirect calorimetry, near-infrared spectroscopy, and A-V difference measurements, can only provide information at the pulmonary or muscular level, we are limited in deriving inferences about the metabolic control solely based on this information. Specifically, these techniques can neither provide reliable measurements of the rate of mitochondrial oxygen consumption (VO2 m) nor provide a quantitative relationship of the dependence of VO2 m on ADP, Pi, NADH and available cellular O2, especially at the onset of exercise in an in vivo contracting skeletal muscle.

The computational model of skeletal muscle metabolism that we developed permits quantitative evaluation of current hypotheses of pathway activation with increase in work rate (ATP demand). Specifically, we investigated two mechanisms of pathway activation: (i) feedback activation via the products ADP, Pi and NADH and (ii) feedforward activation through parallel activation of each reaction in the pathways of ATP formation. Accordingly, we investigated the effect of increased [ADP] and [Pi] induced by an increased ATP hydrolysis rate – equivalent to a change in work rate (WR) – on the activation of glycogenolysis, glycolysis, pyruvate oxidation, fatty acid oxidation, Krebs cycle, and oxidative phosphorylation. Simulations revealed that the increases in [ADP] and [Pi] were not sufficient to increase the reaction flux rates of the reaction processes involved in providing the corresponding amount of reducing equivalents per unit time to the mitochondria in proportion to the rates of O2 utilization and ATP turnover (results not shown). We then investigated the effect of simultaneously increasing maximal reaction velocities (Vmax) of most catalytic reactions participating in energy metabolism in proportion to the increase in metabolic rate (parallel activation as described in the Methods section). Simulations indicated that only by altering simultaneously the Vmax parameters of the reaction flux expressions, it is possible to obtain physiologically meaningful predictions of the metabolic responses to exercise (see Figures 3, 4, 5, 6). Though the exact mechanisms of "parallel activation" have not been clearly elucidated, it may in part be attributed to the stimulation of the activities of mitochondrial dehydrogenases by the levels of free calcium [Ca2+] and/or other enzymes by catecholamines [29,34-37], which are in fact activated by neural stimulation [38-40]. The mechanism may also be attributed to other regulatory mechanisms (known or unknown), such as the regulation of TCA cycle and oxidative phosphorylation fluxes through phosphates [76], that have not been accounted for in this phenomenological model of skeletal muscle bioenergetics.

Muscle oxygen uptake dynamics

Different model-simulated time courses of the increase in muscle oxygen uptake (VO2) toward its steady-state in response to a step change in work rate were obtained in chronically-loaded and unloaded muscle (Fig. 8). There is evidence that pulmonary VO2 reaches steady-state faster in a well-trained individual than in a sedentary individual at the same absolute work rate [27]. However, at moderate exercise intensities (WR ≤ 40% VO2 max), significant differences are not seen between trained or loaded and sedentary subjects until approximately 30 seconds into the exercise bout [27]. Our simulations show similar findings in muscle VO2 dynamics, with minor differences between loaded and unloaded responses earlier in the exercise period.

The differences in the dynamics of muscle VO2 between loading states at exercise onset may be due to a faster muscle blood flow dynamics and thus increased rate of O2 delivery [25,53], or due to a higher oxidative capacity of chronically-loaded muscle [70]. Initially, we hypothesized that the differences in muscle VO2 between loading states were due to the faster blood flow response to exercise in chronically-loaded muscle as observed experimentally [53]. The faster delivery of O2 to contracting muscle in trained individuals would allow improvements in the transient metabolic responses to exercise, thus permitting a closer coupling between the rates ATP production and ATP utilization and a decreased reliance on anaerobic energy sources such as phosphocreatine and glycogen. A smaller glycogenolytic flux would lead to lower production rates of pyruvate and, ultimately lactate, in chronically loaded muscle.

By performing in silico experiments (i.e., computer simulations), it was possible to examine quantitatively the source of the differences in muscle VO2 dynamic responses in the three different loading states. By increasing the rate of muscle blood flow at the onset of exercise, with different time profiles but same steady-state value, we could determine if the rate of O2 delivery to contracting muscle is limiting. Model simulation showed that, during moderate exercise, regardless of the time profile of blood flow, muscle VO2 increased exponentially with similar time constants, τVO2. This suggests that differences in muscle VO2 dynamics characteristic of these loading states – during moderate exercise – may be due to cellular adaptations in oxidative machinery (i.e., levels of metabolic controllers and/or enzyme activation) and not to the kinetics of muscle blood flow.

Phosphorylation ratio differences among muscle loading states during exercise

Various experimental studies have observed smaller increases in [ADP]/[ATP] ratio for trained compared with sedentary individuals during exercise [62,65]. The difference in this ratio between chronically loaded and unloaded muscle in our model is even more drastic (Fig. 9). The increased levels of resting maximal enzyme activity for the oxidative phosphorylation pathway in trained muscle are associated with a greater capacity for increasing reaction velocity and reducing ADP/ATP ratio. In our simulations, the steady-state oxidative phosphorylation flux is the same regardless of the conditioned state of the muscle during moderate-intensity exercise; however, in chronically loaded muscle, a lower ADP/ATP ratio is needed in order to reach this steady-state level. Since this control ratio plays a major role in fine-tuning the flux rates of glycolysis, fat oxidation, and phosphocreatine breakdown, a lower ADP/ATP ratio would result in a tighter coupling of the processes of ATP production and utilization and sparing of fuels and energy stores. For instance, phosphocreatine acts as a buffer to maintain ATP homeostasis and the creatine kinase reaction rate is highly sensitive to changes in ADP/ATP. Simulations showed a smaller decline in ATP concentration and less phosphocreatine breakdown at exercise onset in chronically-loaded muscle during exercise, similar to what is seen experimentally [62,65].

ATP also plays a key role in the activation of both exogenous glucose and fatty acids and in controlling the rates of glycogen synthesis. Glycogen synthase, the enzyme responsible for the synthesis of glycogen from G6P, is activated by ATP. In chronically loaded muscle, there is a lower net glycogen breakdown when compared with unloaded muscle during exercise due to increased rates of glycogen formation as a result of increased ATP levels. A lower rate of glycolysis leads to a lower rate of lactate production as seen in chronically-loaded muscle compared with unloaded muscle during exercise [13,65]. Since lactate concentrations in muscle were similar during moderate exercise regardless of loading state, the increased production of lactate was coupled with higher net release rates in chronically unloaded muscle. This result is in agreement with experimental observations [13,65,77].

Transient lactate metabolic responses to exercise

A noteworthy observation from our simulations is the transient response of net lactate production during exercise. At the onset of exercise, net lactate production increases dramatically, and then declines rapidly to a value near its resting value before increasing again in an exponential fashion to its elevated steady-state level (Fig. 13). This is a triphasic behavior. The early large production of lactate is consistent with the previous experimental finding by Connett et al. [44]. The reason for this is unknown; however, one explanation may be a delay in the activation of the enzyme lactate dehydrogenase (LDH). The activation of intracellular enzymes occurs at the beginning of exercise, and all reaction fluxes increase proportionately as per parallel activation hypothesis. Lactate and pyruvate are substrates in an equilibrium reaction catalyzed by the enzyme LDH, which is also coupled to the redox ratio NADH/NAD+. As exercise starts, NADH drops rapidly to its new steady-state value, causing the LDH reaction to shift towards pyruvate production. As glycolysis increases towards its new steady state, the production of pyruvate from carbohydrates increases which overrides the decrease of NADH, shifting the LDH equilibrium back towards lactate production. A more extensive experimental look at this profile is required to try to determine the causes of the behavior of this transient response, or to refute its existence entirely.

Acetyl-CoA production during exercise

Increased flux through fat oxidation pathway leads to higher rates of acetyl-CoA production from fatty acids in chronically loaded muscle compared to unloaded muscle during exercise. Chronically unloaded muscle, with its higher flux through glycolytic pathway, produces more pyruvate, which leads to increased levels of acetyl-CoA from carbohydrates than chronically loaded muscle (Fig. 15). Studies have shown that following endurance training, insignificant changes are measured both in the total and active concentrations for pyruvate dehydrogenase (PDH), the enzyme responsible for oxidizing pyruvate to acetyl-CoA [65]. In our model, PDH maximal reaction velocity was the same for all three loading states. Thus, reductions in pyruvate oxidation for chronically loaded muscle during exercise are most likely due to the decreased availability of pyruvate from glycogenolysis and glycolysis. Additional inhibition of this reaction by its product may also play some role, as increased levels of acetyl-CoA from fat oxidation may inhibit its production from carbohydrates. While experimental techniques may not be sensitive enough to measure these fuel differences between chronically-loaded and unloaded states, especially at the exercise intensities performed in these simulations, our model predicts that the respiratory quotients for trained and detrained muscle during moderate-intensity exercise are 0.826 and 0.835, respectively, corresponding to 36% and 40% contributions from carbohydrates towards the production of acetyl-CoA.

Effect of enzyme activation on reaction flux regulation

We have distinguished the roles of various species and controllers in regulating flux rates through various metabolic pathways (Appendix B). While each species and controller does serve key functions, we feel it is important to emphasize that they are responsible only for fine-tuned regulation. The main regulatory control is achieved through both the alterations in the ratio of active/inactive enzyme molecules and different enzymatic adaptations to training and detraining, as proposed by Hochachka and Matheson [52]. As we have shown earlier, the maximal velocity for each enzymatic reaction in our model is coupled with a relative metabolic rate (RMR) term that increases in parallel with increases in ATP turnover rate. For our simulated exercise bout (WR = 65W), we could induce a 14-fold increase in the ATP hydrolysis rate that we feel is representative of moderate-intensity exercise. In order for us to closely match this increased rate of ATP-utilization, the ATP-producing pathways must increase its flux turnover capacity to similar levels. As was mentioned earlier, it is not possible for this to be achieved strictly through changes in species concentration only (e.g., feedback activation by ADP, Pi and NADH), and thus we felt it was appropriate to increase the Vmax for each reaction in parallel by some factor similar for all states (parallel activation). This approach has been done in other in silico research that has attempted to study the regulation of ATP turnover rates during exercise [29,34-37].

Model limitations and future developments

In this model of skeletal muscle metabolism, the cytosolic and mitochondrial regions were not distinguished. Consequently, for some physiological stresses such as heavy-intensity exercise, the model may not accurately predict the dynamics of several metabolite concentrations and reaction fluxes that are critical in the regulation of cellular respiration and fuel (carbohydrate, fat and lactate) metabolism. For example, the modulators of several key metabolic reactions in cytosol and mitochondria ([ATP]/[ADP] and [NADH]/[NAD+]) have different concentrations in these subcellular domains [48]. Another limitation in this model is that most of the lumped enzymatic reactions in the cellular biochemical pathways were considered irreversible in the direction of product formation. In principle, almost all cellular metabolic reactions are essentially reversible [31,33] and are governed by thermodynamic equilibrium conditions [30,50]. Under typical physiological conditions, which are far from the equilibrium, however, most metabolic fluxes are typically dominant in one direction although their magnitudes can change during some pathological conditions.

A more physiologically and biochemically mechanistic model of skeletal muscle metabolism should include the distinction of cytosol and mitochondrial domains within the tissue cells. Also, the subcellular compartmentation could account for distinct regions of metabolite distribution, for example, associated with glycolysis [48]. Furthermore, alternative kinetic flux expressions can be based on Michaelis-Menten formalism for reversible enzymatic reactions satisfying Haldane relationship that apply for thermodynamic equilibrium [30,31,49,50]. This would provide additional thermodynamic constraints on maximal reaction velocities.

Conclusion

We successfully extended a previously developed model of skeletal muscle metabolism and obtained agreement with experimental data under several different physiological conditions for sedentary muscle. By selecting kinetic model parameter values in agreement with alterations in enzymes contents/activities induced by chronic loading and unloading, we were able to identify differences in fuel preference and delivery of arterial species during moderate-intensity exercise. In particular, we were able to examine – with computer simulations – the impact of cellular metabolic adaptations induced by chronic unloading/loading on the dynamics of various exercise responses. Chronically loaded muscle displayed a faster muscle VO2 kinetic response to a step increase in work rate. Unloaded muscle oxidized a larger percentage of carbohydrates for ATP synthesis during exercise. This increase in carbohydrates utilization also leads to higher rates of intramuscular lactate formation. With the proposed enhancements and with additional metabolic pathways similar to those of the model of cardiac metabolism [48], a model of skeletal muscle metabolism could be applied to test complex hypotheses involving the integration of cellular metabolic networks and responses during exercise in individuals who have undergone periods of training (loading) or chronic physical inactivity (unloading).

Appendix A: Dynamic mass balance equations

Table 6.

Glucose (GLU) VcdCc,GLUdt=φGLUG6P+Q(Ca,GLUσGLUCc,GLU) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbEeahjabbYeamjabbwfavbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0JaeyOeI0ccciGae8NXdy2aaSbaaSqaaiabbEeahjabbYeamjabbwfavjabgkziUkabbEeahjabbAda2iabbcfaqbqabaGccqGHRaWkcqWGrbqucqGGOaakcqWGdbWqdaWgaaWcbaGaeeyyaeMaeeilaWIaee4raCKaeeitaWKaeeyvaufabeaakiabgkHiTiab=n8aZnaaBaaaleaacqqGhbWrcqqGmbatcqqGvbqvaeqaaOGaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbEeahjabbYeamjabbwfavbqabaGccqGGPaqkaaa@5E74@
Glucose 6-Phosphate (G6P) VcdCc,G6Pdt=φGLUG6P+φGLYG6PφG6PGLYφG6PGA3P MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbEeahjabbAda2iabbcfaqbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbEeahjabbYeamjabbwfavjabgkziUkabbEeahjabbAda2iabbcfaqbqabaGccqGHRaWkcqWFgpGzdaWgaaWcbaGaee4raCKaeeitaWKaeeywaKLaeyOKH4Qaee4raCKaeeOnayJaeeiuaafabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGhbWrcqqG2aGncqqGqbaucqGHsgIRcqqGhbWrcqqGmbatcqqGzbqwaeqaaOGaeyOeI0Iae8NXdy2aaSbaaSqaaiabbEeahjabbAda2iabbcfaqjabgkziUkabbEeahjabbgeabjabbodaZiabbcfaqbqabaaaaa@6874@
Glycogen (GLY) VcdCc,GLYdt=φG6PGLYφGLYG6P MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbEeahjabbYeamjabbMfazbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbEeahjabbAda2iabbcfaqjabgkziUkabbEeahjabbYeamjabbMfazbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaee4raCKaeeitaWKaeeywaKLaeyOKH4Qaee4raCKaeeOnayJaeeiuaafabeaaaaa@5140@
Glyceraldehyde 3-Phosphate (GA3P) VcdCc,GA3Pdt=2φG6PGA3PφGA3PBPG MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbEeahjabbgeabjabbodaZiabbcfaqbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0JaeGOmaidcciGae8NXdy2aaSbaaSqaaiabbEeahjabbAda2iabbcfaqjabgkziUkabbEeahjabbgeabjabbodaZiabbcfaqbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaee4raCKaeeyqaeKaee4mamJaeeiuaaLaeyOKH4QaeeOqaiKaeeiuaaLaee4raCeabeaaaaa@5499@
1,3-Biphospho glycerate (BPG) VcdCc,BPGdt=φGA3PBPGφBPGPYR MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbkeacjabbcfaqjabbEeahbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbEeahjabbgeabjabbodaZiabbcfaqjabgkziUkabbkeacjabbcfaqjabbEeahbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeOqaiKaeeiuaaLaee4raCKaeyOKH4QaeeiuaaLaeeywaKLaeeOuaifabeaaaaa@522D@
Pyruvate (PYR) VcdCc,PYRdt=φBPGPYR+φLACPYRφPYRLACφPYRALAφPYRACoA+Q(Ca,PYRσPYRCc,PYR) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaafaqadeGabaaabaGaemOvay1aaSbaaSqaaiabbogaJbqabaGcdaWcaaqaaiabdsgaKjabdoeadnaaBaaaleaacqqGJbWycqqGSaalcqqGqbaucqqGzbqwcqqGsbGuaeqaaaGcbaGaemizaqMaemiDaqhaaiabg2da9GGaciab=z8aMnaaBaaaleaacqqGcbGqcqqGqbaucqqGhbWrcqGHsgIRcqqGqbaucqqGzbqwcqqGsbGuaeqaaOGaey4kaSIae8NXdy2aaSbaaSqaaiabbYeamjabbgeabjabboeadjabgkziUkabbcfaqjabbMfazjabbkfasbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeiuaaLaeeywaKLaeeOuaiLaeyOKH4QaeeitaWKaeeyqaeKaee4qameabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGqbaucqqGzbqwcqqGsbGucqGHsgIRcqqGbbqqcqqGmbatcqqGbbqqaeqaaaGcbaGaeyOeI0Iae8NXdy2aaSbaaSqaaiabbcfaqjabbMfazjabbkfasjabgkziUkabbgeabjabboeadjabb+gaVjabbgeabbqabaGccqGHRaWkcqWGrbqucqGGOaakcqWGdbWqdaWgaaWcbaGaeeyyaeMaeeilaWIaeeiuaaLaeeywaKLaeeOuaifabeaakiabgkHiTiab=n8aZnaaBaaaleaacqqGqbaucqqGzbqwcqqGsbGuaeqaaOGaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbcfaqjabbMfazjabbkfasbqabaGccqGGPaqkaaaaaa@8DBC@
Lactate (LAC) VcdCc,LACdt=φPYRLACφLACPYR+Q(Ca,LACσLACCc,LAC) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@6877@
Alanine (ALA) VcdCc,ALAdt=φPYRALA+Q(Ca,ALAσALACc,ALA) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbgeabjabbYeamjabbgeabbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbcfaqjabbMfazjabbkfasjabgkziUkabbgeabjabbYeamjabbgeabbqabaGccqGHRaWkcqWGrbqucqGGOaakcqWGdbWqdaWgaaWcbaGaeeyyaeMaeeilaWIaeeyqaeKaeeitaWKaeeyqaeeabeaakiabgkHiTiab=n8aZnaaBaaaleaacqqGbbqqcqqGmbatcqqGbbqqaeqaaOGaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbgeabjabbYeamjabbgeabbqabaGccqGGPaqkaaa@5CDF@
Triglycerides (TGL) VcdCc,TGLdt=φGLCTGLφTGLGLC+Q(Ca,TGLσTGLCc,TGL) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@68F7@
Glycerol (GLC) VcdCc,GLCdt=φTGLGLCφGLCTGL+Q(Ca,GLCσGLCCc,GLC) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@686F@
Free Fatty Acid (FFA) VcdCc,FFAdt=3φTGLGLC3φGLCTGLφFFAFAC+Q(Ca,FFAσFFACc,FFA) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbAeagjabbAeagjabbgeabbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0JaeG4mamdcciGae8NXdy2aaSbaaSqaaiabbsfaujabbEeahjabbYeamjabgkziUkabbEeahjabbYeamjabboeadbqabaGccqGHsislcqaIZaWmcqWFgpGzdaWgaaWcbaGaee4raCKaeeitaWKaee4qamKaeyOKH4QaeeivaqLaee4raCKaeeitaWeabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGgbGrcqqGgbGrcqqGbbqqcqGHsgIRcqqGgbGrcqqGbbqqcqqGdbWqaeqaaOGaey4kaSIaemyuaeLaeiikaGIaem4qam0aaSbaaSqaaiabbggaHjabbYcaSiabbAeagjabbAeagjabbgeabbqabaGccqGHsislcqWFdpWCdaWgaaWcbaGaeeOrayKaeeOrayKaeeyqaeeabeaakiabdoeadnaaBaaaleaacqqGJbWycqqGSaalcqqGgbGrcqqGgbGrcqqGbbqqaeqaaOGaeiykaKcaaa@752B@
Fatty Acyl-CoA (FAC) VcdCc,FACdt=φFFAFACφFACACoA MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbAeagjabbgeabjabboeadbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbAeagjabbAeagjabbgeabjabgkziUkabbAeagjabbgeabjabboeadbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeOrayKaeeyqaeKaee4qamKaeyOKH4QaeeyqaeKaee4qamKaee4Ba8Maeeyqaeeabeaaaaa@51C9@
Acetyl-CoA (ACoA) VcdCc,ACoAdt=φPYRACoA+8φFACACoAφACoACIT MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbgeabjabboeadjabb+gaVjabbgeabbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbcfaqjabbMfazjabbkfasjabgkziUkabbgeabjabboeadjabb+gaVjabbgeabbqabaGccqGHRaWkcqaI4aaocqWFgpGzdaWgaaWcbaGaeeOrayKaeeyqaeKaee4qamKaeyOKH4QaeeyqaeKaee4qamKaee4Ba8MaeeyqaeeabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGbbqqcqqGdbWqcqqGVbWBcqqGbbqqcqGHsgIRcqqGdbWqcqqGjbqscqqGubavaeqaaaaa@626B@
Citrate (CIT) VcdCc,CITdt=φACoACITφCITAKG MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabboeadjabbMeajjabbsfaubqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbgeabjabboeadjabb+gaVjabbgeabjabgkziUkabboeadjabbMeajjabbsfaubqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaee4qamKaeeysaKKaeeivaqLaeyOKH4QaeeyqaeKaee4saSKaee4raCeabeaaaaa@5259@
α-Ketoglutarate (AKG) VcdCc,AKGdt=φCITAKGφAKGSCoA MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbgeabjabbUealjabbEeahbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabboeadjabbMeajjabbsfaujabgkziUkabbgeabjabbUealjabbEeahbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeyqaeKaee4saSKaee4raCKaeyOKH4Qaee4uamLaee4qamKaee4Ba8Maeeyqaeeabeaaaaa@5249@
Succinyl-CoA (SCoA) VcdCc,SCoAdt=φAKGSCoAφSCoASUC MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbofatjabboeadjabb+gaVjabbgeabbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbgeabjabbUealjabbEeahjabgkziUkabbofatjabboeadjabb+gaVjabbgeabbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaee4uamLaee4qamKaee4Ba8MaeeyqaeKaeyOKH4Qaee4uamLaeeyvauLaee4qameabeaaaaa@5539@
Succinate (SUC) VcdCc,SUCdt=φSCoASUCφSUCMAL MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbofatjabbwfavjabboeadbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbofatjabboeadjabb+gaVjabbgeabjabgkziUkabbofatjabbwfavjabboeadbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaee4uamLaeeyvauLaee4qamKaeyOKH4Qaeeyta0KaeeyqaeKaeeitaWeabeaaaaa@52CD@
Malate (MAL) VcdCc,MALdt=φSUCMALφMALOXA MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabb2eanjabbgeabjabbYeambqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbofatjabbwfavjabboeadjabgkziUkabb2eanjabbgeabjabbYeambqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeyta0KaeeyqaeKaeeitaWKaeyOKH4Qaee4ta8KaeeiwaGLaeeyqaeeabeaaaaa@5146@
Oxaloacetate (OXA) VcdCc,OXAdt=φMALOXAφACoACIT MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabb+eapjabbIfayjabbgeabbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabb2eanjabbgeabjabbYeamjabgkziUkabb+eapjabbIfayjabbgeabbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeyqaeKaee4qamKaee4Ba8MaeeyqaeKaeyOKH4Qaee4qamKaeeysaKKaeeivaqfabeaaaaa@5287@
CO2 VcdCc,CO2dt=φPYRACoA+φCITAKG+φAKGSCoA+Q(Ca,CO2σCO2Cc,CO2) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@75D0@
O2 VcdCc,O2dt=φO2H2O+Q(Ca,O2σO2Cc,O2) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabb+eapjabbkdaYaqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0JaeyOeI0ccciGae8NXdy2aaSbaaSqaaiabb+eapjabbkdaYiabgkziUkabbIeaijabbkdaYiabb+eapbqabaGccqGHRaWkcqWGrbqucqGGOaakcqWGdbWqdaWgaaWcbaGaeeyyaeMaeeilaWIaee4ta8KaeeOmaidabeaakiabgkHiTiab=n8aZnaaBaaaleaacqqGpbWtcqqGYaGmaeqaaOGaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabb+eapjabbkdaYaqabaGccqGGPaqkaaa@57C3@
PCr VcdCc,PCRdt=φCRPCRφPCRCR MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbcfaqjabboeadjabbkfasbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabboeadjabbkfasjabgkziUkabbcfaqjabboeadjabbkfasbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeiuaaLaee4qamKaeeOuaiLaeyOKH4Qaee4qamKaeeOuaifabeaaaaa@4F28@
Cr VcdCc,CRdt=φPCRCRφCRPCR MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabboeadjabbkfasbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbcfaqjabboeadjabbkfasjabgkziUkabboeadjabbkfasbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaee4qamKaeeOuaiLaeyOKH4QaeeiuaaLaee4qamKaeeOuaifabeaaaaa@4E01@
Pi VcdCc,Pidt=2φG6PGLY+7φGLCTGL+2φFFAFAC+φATPADPφGLYG6PφGA3PBPGφSCoASUC5.64φO2H2O MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaafaqadeGabaaabaGaemOvay1aaSbaaSqaaiabbogaJbqabaGcdaWcaaqaaiabdsgaKjabdoeadnaaBaaaleaacqqGJbWycqqGSaalcqqGqbaucqqGPbqAaeqaaaGcbaGaemizaqMaemiDaqhaaiabg2da9iabikdaYGGaciab=z8aMnaaBaaaleaacqqGhbWrcqqG2aGncqqGqbaucqGHsgIRcqqGhbWrcqqGmbatcqqGzbqwaeqaaOGaey4kaSIaeG4naCJae8NXdy2aaSbaaSqaaiabbEeahjabbYeamjabboeadjabgkziUkabbsfaujabbEeahjabbYeambqabaGccqGHRaWkcqaIYaGmcqWFgpGzdaWgaaWcbaGaeeOrayKaeeOrayKaeeyqaeKaeyOKH4QaeeOrayKaeeyqaeKaee4qameabeaakiabgUcaRiab=z8aMnaaBaaaleaacqqGbbqqcqqGubavcqqGqbaucqGHsgIRcqqGbbqqcqqGebarcqqGqbauaeqaaOGaeyOeI0Iae8NXdy2aaSbaaSqaaiabbEeahjabbYeamjabbMfazjabgkziUkabbEeahjabbAda2iabbcfaqbqabaaakeaacqGHsislcqWFgpGzdaWgaaWcbaGaee4raCKaeeyqaeKaee4mamJaeeiuaaLaeyOKH4QaeeOqaiKaeeiuaaLaee4raCeabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGtbWucqqGdbWqcqqGVbWBcqqGbbqqcqGHsgIRcqqGtbWucqqGvbqvcqqGdbWqaeqaaOGaeyOeI0IaeGynauJaeiOla4IaeGOnayJaeGinaqJae8NXdy2aaSbaaSqaaiabb+eapjabbkdaYiabgkziUkabbIeaijabbkdaYiabb+eapbqabaaaaaaa@9BE2@
CoA VcdCc,CoAdt=φACoACIT+φSCoASUCφPYRACoAφFFAFAC7φFACACoAφAKGSCoA MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaafaqadeGabaaabaGaemOvay1aaSbaaSqaaiabbogaJbqabaGcdaWcaaqaaiabdsgaKjabdoeadnaaBaaaleaacqqGJbWycqqGSaalcqqGdbWqcqqGVbWBcqqGbbqqaeqaaaGcbaGaemizaqMaemiDaqhaaiabg2da9GGaciab=z8aMnaaBaaaleaacqqGbbqqcqqGdbWqcqqGVbWBcqqGbbqqcqGHsgIRcqqGdbWqcqqGjbqscqqGubavaeqaaOGaey4kaSIae8NXdy2aaSbaaSqaaiabbofatjabboeadjabb+gaVjabbgeabjabgkziUkabbofatjabbwfavjabboeadbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeiuaaLaeeywaKLaeeOuaiLaeyOKH4QaeeyqaeKaee4qamKaee4Ba8MaeeyqaeeabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGgbGrcqqGgbGrcqqGbbqqcqGHsgIRcqqGgbGrcqqGbbqqcqqGdbWqaeqaaOGaeyOeI0IaeG4naCJae8NXdy2aaSbaaSqaaiabbAeagjabbgeabjabboeadjabgkziUkabbgeabjabboeadjabb+gaVjabbgeabbqabaaakeaacqGHsislcqWFgpGzdaWgaaWcbaGaeeyqaeKaee4saSKaee4raCKaeyOKH4Qaee4uamLaee4qamKaee4Ba8Maeeyqaeeabeaaaaaaaa@8609@
NADH VcdCc,NADHdt=φGA3PBPG+φLACPYR+φPYRACoA+353φFACACoA+φCITAKG+φAKGSCoA+23φSUCMAL+φMALOXAφPYRLAC1.88φO2H2O MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaafaqadeGabaaabaGaemOvay1aaSbaaSqaaiabbogaJbqabaGcdaWcaaqaaiabdsgaKjabdoeadnaaBaaaleaacqqGJbWycqqGSaalcqqGobGtcqqGbbqqcqqGebarcqqGibasaeqaaaGcbaGaemizaqMaemiDaqhaaiabg2da9GGaciab=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z8aMnaaBaaaleaacqqGbbqqcqqGlbWscqqGhbWrcqGHsgIRcqqGtbWucqqGdbWqcqqGVbWBcqqGbbqqaeqaaOGaey4kaSYaaSqaaKqaahaacqaIYaGmaeaacqaIZaWmaaGccqWFgpGzdaWgaaWcbaGaee4uamLaeeyvauLaee4qamKaeyOKH4Qaeeyta0KaeeyqaeKaeeitaWeabeaakiabgUcaRiab=z8aMnaaBaaaleaacqqGnbqtcqqGbbqqcqqGmbatcqGHsgIRcqqGpbWtcqqGybawcqqGbbqqaeqaaOGaeyOeI0Iae8NXdy2aaSbaaSqaaiabbcfaqjabbMfazjabbkfasjabgkziUkabbYeamjabbgeabjabboeadbqabaGccqGHsislcqaIXaqmcqGGUaGlcqaI4aaocqaI4aaocqWFgpGzdaWgaaWcbaGaee4ta8KaeeOmaiJaeyOKH4QaeeisaGKaeeOmaiJaee4ta8eabeaaaaaaaa@BAF9@
NAD+ VcdCc,NAD+dt=φPYRLAC+1.88φO2H2OφGA3PBPGφLACPYRφPYRACoA353φFACACoAφCITAKGφAKGSUC23φSUCMALφMALOXA MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaafaqadeGabaaabaGaemOvay1aaSbaaSqaaiabbogaJbqabaGcdaWcaaqaaiabdsgaKjabdoeadnaaBaaaleaacqqGJbWycqqGSaalcqqGobGtcqqGbbqqcqqGebarcqqGRaWkaeqaaaGcbaGaemizaqMaemiDaqhaaiabg2da9GGaciab=z8aMnaaBaaaleaacqqGqbaucqqGzbqwcqqGsbGucqGHsgIRcqqGmbatcqqGbbqqcqqGdbWqaeqaaOGaey4kaSIaeGymaeJaeiOla4IaeGioaGJaeGioaGJae8NXdy2aaSbaaSqaaiabb+eapjabbkdaYiabgkziUkabbIeaijabbkdaYiabb+eapbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaee4raCKaeeyqaeKaee4mamJaeeiuaaLaeyOKH4QaeeOqaiKaeeiuaaLaee4raCeabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGmbatcqqGbbqqcqqGdbWqcqGHsgIRcqqGqbaucqqGzbqwcqqGsbGuaeqaaOGaeyOeI0Iae8NXdy2aaSbaaSqaaiabbcfaqjabbMfazjabbkfasjabgkziUkabbgeabjabboeadjabb+gaVjabbgeabbqabaaakeaacqGHsisldaWcbaqcbaCaaiabiodaZiabiwda1aqaaiabiodaZaaakiab=z8aMnaaBaaaleaacqqGgbGrcqqGbbqqcqqGdbWqcqGHsgIRcqqGbbqqcqqGdbWqcqqGVbWBcqqGbbqqaeqaaOGaeyOeI0Iae8NXdy2aaSbaaSqaaiabboeadjabbMeajjabbsfaujabgkziUkabbgeabjabbUealjabbEeahbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeyqaeKaee4saSKaee4raCKaeyOKH4Qaee4uamLaeeyvauLaee4qameabeaakiabgkHiTmaaleaajeaWbaGaeGOmaidabaGaeG4mamdaaOGae8NXdy2aaSbaaSqaaiabbofatjabbwfavjabboeadjabgkziUkabb2eanjabbgeabjabbYeambqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeyta0KaeeyqaeKaeeitaWKaeyOKH4Qaee4ta8KaeeiwaGLaeeyqaeeabeaaaaaaaa@B9BB@
ATP VcdCc,ATPdt=2φBPGPYR+φSCoASUC+5.64φO2H2O+φPCRCR+φADPAMPφGLUG6PφG6PGLYφG6PGA3P7φGLCTGL2φFFAFACφCRPCRφATPADPφAMPADP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaafaqadeWabaaabaGaemOvay1aaSbaaSqaaiabbogaJbqabaGcdaWcaaqaaiabdsgaKjabdoeadnaaBaaaleaacqqGJbWycqqGSaalcqqGbbqqcqqGubavcqqGqbauaeqaaaGcbaGaemizaqMaemiDaqhaaiabg2da9iabikdaYGGaciab=z8aMnaaBaaaleaacqqGcbGqcqqGqbaucqqGhbWrcqGHsgIRcqqGqbaucqqGzbqwcqqGsbGuaeqaaOGaey4kaSIae8NXdy2aaSbaaSqaaiabbofatjabboeadjabb+gaVjabbgeabjabgkziUkabbofatjabbwfavjabboeadbqabaGccqGHRaWkcqaI1aqncqGGUaGlcqaI2aGncqaI0aancqWFgpGzdaWgaaWcbaGaee4ta8KaeeOmaiJaeyOKH4QaeeisaGKaeeOmaiJaee4ta8eabeaakiabgUcaRiab=z8aMnaaBaaaleaacqqGqbaucqqGdbWqcqqGsbGucqGHsgIRcqqGdbWqcqqGsbGuaeqaaOGaey4kaSIae8NXdy2aaSbaaSqaaiabbgeabjabbseaejabbcfaqjabgkziUkabbgeabjabb2eanjabbcfaqbqabaaakeaacqGHsislcqWFgpGzdaWgaaWcbaGaee4raCKaeeitaWKaeeyvauLaeyOKH4Qaee4raCKaeeOnayJaeeiuaafabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGhbWrcqqG2aGncqqGqbaucqGHsgIRcqqGhbWrcqqGmbatcqqGzbqwaeqaaOGaeyOeI0Iae8NXdy2aaSbaaSqaaiabbEeahjabbAda2iabbcfaqjabgkziUkabbEeahjabbgeabjabbodaZiabbcfaqbqabaGccqGHsislcqaI3aWncqWFgpGzdaWgaaWcbaGaee4raCKaeeitaWKaee4qamKaeyOKH4QaeeivaqLaee4raCKaeeitaWeabeaakiabgkHiTiabikdaYiab=z8aMnaaBaaaleaacqqGgbGrcqqGgbGrcqqGbbqqcqGHsgIRcqqGgbGrcqqGbbqqcqqGdbWqaeqaaaGcbaGaeyOeI0Iae8NXdy2aaSbaaSqaaiabboeadjabbkfasjabgkziUkabbcfaqjabboeadjabbkfasbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeyqaeKaeeivaqLaeeiuaaLaeyOKH4QaeeyqaeKaeeiraqKaeeiuaafabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGbbqqcqqGnbqtcqqGqbaucqGHsgIRcqqGbbqqcqqGebarcqqGqbauaeqaaaaaaaa@D38C@
ADP VcdCc,ADPdt=φGLUG6P+φG6PGLY+φG6PGA3P+7φGLCTGL+2φFFAFAC+φCRPCR+φATPADP+2φAMPADP2φBPGPYRφSCoASUC5.64φO2H2OφPCRCR2φADPAMP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaafaqadeWabaaabaGaemOvay1aaSbaaSqaaiabbogaJbqabaGcdaWcaaqaaiabdsgaKjabdoeadnaaBaaaleaacqqGJbWycqqGSaalcqqGbbqqcqqGebarcqqGqbauaeqaaaGcbaGaemizaqMaemiDaqhaaiabg2da9GGaciab=z8aMnaaBaaaleaacqqGhbWrcqqGmbatcqqGvbqvcqGHsgIRcqqGhbWrcqqG2aGncqqGqbauaeqaaOGaey4kaSIae8NXdy2aaSbaaSqaaiabbEeahjabbAda2iabbcfaqjabgkziUkabbEeahjabbYeamjabbMfazbqabaGccqGHRaWkcqWFgpGzdaWgaaWcbaGaee4raCKaeeOnayJaeeiuaaLaeyOKH4Qaee4raCKaeeyqaeKaee4mamJaeeiuaafabeaakiabgUcaRiabiEda3iab=z8aMnaaBaaaleaacqqGhbWrcqqGmbatcqqGdbWqcqGHsgIRcqqGubavcqqGhbWrcqqGmbataeqaaOGaey4kaSIaeGOmaiJae8NXdy2aaSbaaSqaaiabbAeagjabbAeagjabbgeabjabgkziUkabbAeagjabbgeabjabboeadbqabaaakeaacqGHRaWkcqWFgpGzdaWgaaWcbaGaee4qamKaeeOuaiLaeyOKH4QaeeiuaaLaee4qamKaeeOuaifabeaakiabgUcaRiab=z8aMnaaBaaaleaacqqGbbqqcqqGubavcqqGqbaucqGHsgIRcqqGbbqqcqqGebarcqqGqbauaeqaaOGaey4kaSIaeeOmaiJae8NXdy2aaSbaaSqaaiabbgeabjabb2eanjabbcfaqjabgkziUkabbgeabjabbseaejabbcfaqbqabaGccqGHsislcqaIYaGmcqWFgpGzdaWgaaWcbaGaeeOqaiKaeeiuaaLaee4raCKaeyOKH4QaeeiuaaLaeeywaKLaeeOuaifabeaakiabgkHiTiab=z8aMnaaBaaaleaacqqGtbWucqqGdbWqcqqGVbWBcqqGbbqqcqGHsgIRcqqGtbWucqqGvbqvcqqGdbWqaeqaaaGcbaGaeyOeI0IaeGynauJaeiOla4IaeGOnayJaeGinaqJae8NXdy2aaSbaaSqaaiabb+eapjabbkdaYiabgkziUkabbIeaijabbkdaYiabb+eapbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeiuaaLaee4qamKaeeOuaiLaeyOKH4Qaee4qamKaeeOuaifabeaakiabgkHiTiabikdaYiab=z8aMnaaBaaaleaacqqGbbqqcqqGebarcqqGqbaucqGHsgIRcqqGbbqqcqqGnbqtcqqGqbauaeqaaaaaaaa@D528@
AMP VcdCc,AMPdt=φADPAMPφAMPADP MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGwbGvdaWgaaWcbaGaee4yamgabeaakmaalaaabaGaemizaqMaem4qam0aaSbaaSqaaiabbogaJjabbYcaSiabbgeabjabb2eanjabbcfaqbqabaaakeaacqWGKbazcqWG0baDaaGaeyypa0dcciGae8NXdy2aaSbaaSqaaiabbgeabjabbseaejabbcfaqjabgkziUkabbgeabjabb2eanjabbcfaqbqabaGccqGHsislcqWFgpGzdaWgaaWcbaGaeeyqaeKaeeyta0KaeeiuaaLaeyOKH4QaeeyqaeKaeeiraqKaeeiuaafabeaaaaa@510C@

Appendix B: Metabolic reaction flux expressions

Table 7.

1. Glucose Utilization GLU + ATP → G6P + ADP
φGLUG6P=VGLUG6P(CATPCADPKATPADP+CATPCADP)(CGLUKGLU1+CGLUKGLU+CG6PKG6P) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@7F39@
2. Glycogen Synthesis G6P + ATP → GLY + ADP + 2 Pi
φG6PGLY=VG6PGLY(CATPCADPKATPADP+CATPCADP)(CG6PKG6P1+CG6PKG6P+CGLYKGLY+CPiKPi+CGLYKGLYCPiKPi) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@9BD3@
This is lumping of 4 reactions G6P ↔ G1P, G1P + UTP → UDP-GLC + 2 Pi, UDP-GLC + GLYn → UDP + GLYn+1, and UDP + ATP → UTP + ADP.
3. Glycogen Utilization GLY + Pi + G6P
φGLYG6P=VGLYG6P(CAMPCATPKAMPATP+CAMPCATP)(CGLYKGLYCPiKPi1+CGLYKGLY+CPiKPi+CGLYKGLYCPiKPi+CG6PKG6P) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@A679@
This is lumping of 2 reactions GLY + Pi → G1P and G1P ↔ G6P. The activity of the enzyme glycogen phosphorylase is regulated by AMP and ATP [51]; AMP acts as a positive effector (activator) and ATP acts a negative effector (inhibitor) by competing with AMP. So the reaction is controlled by CAMP/CATP concentration ratio.
4. Glucose 6-Phosphate Breakdown G6P + ATP → 2 GA3P + ADP
φG6PGA3P=VG6PGA3P(CAMPCATPKAMPATP+CAMPCATP)(CG6PKG6P1+CG6PKG6P+CGA3PKGA3P) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@8237@
This is lumping of 4 reactions G6P ↔ F6P, F6P + ATP → F16BP + ADP, F16BP ↔ DHAP + GA3P, and DHAP ↔ GA3P. The activity of the enzyme phosphofructo kinase in this reaction is assumed to be regulated by the energy metabolite concentration ratio CAMP/CATP.
5. Glyceraldehyde 3-Phosphate Breakdown GA3P + Pi + NAD+ → BPG + NADH
φGA3PBPG=VGA3PBPG(CNAD+CNADHKNAD+NADH+CNAD+CNADH)(CGA3PKGA3PCPiKPi1+CGA3PKGA3P+CPiKPi+CGA3PKGA3PCPiKPi+CBPGKBPG) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@B2B6@
6. Pyruvate Production BPG + 2 ADP → PYR + 2 ATP
φBPGPYR=VBPGPYR(CADPCATPKADPATP+CADPCATP)(CBPGKBPG1+CBPGKBPG+CPYRKPYR) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@7FF5@
This is lumping of 4 reactions 13BPG + ADP ↔ 3PG + ATP, 3PG ↔ 2PG, 2PG ↔ PEP, and PEP+ADP → PYR + ATP.
7. Pyruvate Reduction PYR + NADH → LAC + NAD+
φPYRLAC=VPYRLAC(CNADHCNAD+KNADHNAD++CNADHCNAD+)(CPYRKPYR1+CPYRKPYR+CLACKLAC) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@8623@
8. Lactate Oxidation LAC + NAD+ + PYR + NADH
φLACPYR=VLACPYR(CNAD+CNADHKNAD+NADH+CNAD+CNADH)(CLACKLAC1+CLACKLAC+CPYRKPYR) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@8574@
9. Alanine Production PYR → ALA
φPYRALA=VPYRALA(CPYRKPYR1+CPYRKPYR+CALAKALA) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFgpGzlmaaBaaabaGaeeiuaaLaeeywaKLaeeOuaiLaeyOKH4QaeeyqaeKaeeitaWKaeeyqaeeabeaakiabg2da9iabdAfawnaaBaaaleaacqqGqbaucqqGzbqwcqqGsbGucqGHsgIRcqqGbbqqcqqGmbatcqqGbbqqaOqabaWaaeWaaeaadaWcaaqaamaalaaabaGaem4qam0cdaWgaaqaaiabbcfaqjabbMfazjabbkfasbqabaaakeaacqWGlbWsdaWgaaWcbaGaeeiuaaLaeeywaKLaeeOuaifakeqaaaaaaeaacqqGXaqmcqGHRaWkdaWcaaqaaiabdoeadTWaaSbaaeaacqqGqbaucqqGzbqwcqqGsbGuaeqaaaGcbaGaem4saS0aaSbaaSqaaiabbcfaqjabbMfazjabbkfasbGcbeaaaaGaey4kaSYaaSaaaeaacqWGdbWqlmaaBaaabaGaeeyqaeKaeeitaWKaeeyqaeeabeaaaOqaaiabdUealnaaBaaaleaacqqGbbqqcqqGmbatcqqGbbqqaOqabaaaaaaaaiaawIcacaGLPaaaaaa@6337@
10. Pyruvate Oxidation PYR + CoA + NAD+ → ACoA + NADH + CO2
φPYRACoA=VPYRACoA(CNAD+CNADHKNAD+NADH+CNAD+CNADH)(CPYRKPYRCCoAKCoA1+CPYRKPYR+CCoAKCoA+CPYRKPYRCCoAKCoA+CACoAKACoA+CCO2KCO2+CACoAKACoACCO2KCO2) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@D9DC@
This reaction links between glycolysis and TCA cycle inside the mitochondrial matrix and contributes to ACoA formation from the carbohydrates.
11. Lipolysis TGL → GLC + 3 FFA
φTGLGLC=VTGLGLC(CTGLKTGL1+CTGLKTGL+CFFAKFFA+CGLCKGLC+CFFAKFFACGLCKGLC) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@81D1@
12. Triglyceride Synthesis GLC + 3 FFA + 7 ATP → TGL + 7 ADP + 7 Pi
φGLCTGL=VGLCTGL(CATPCADPKATPADP+CATPCADP)(CFFAKFFACGLCKGLC1+CFFAKFFA+CGLCKGLC+CFFAKFFACGLCKGLC+CTGLKTGL+CPiKPi+CTGLKTGLCPiKPi) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@C69F@
This is lumping of 3 reactions GLC + ATP → G3P + ADP, G3P + 3FAC → TGL + 3CoA + Pi, 3FFA + 3CoA + 6ATP → 3FAC + 6ATP + 6Pi. For simplicity, TGL synthesis from DHAP or GA3P (glycolysis) and FAC has been ignored.
13. Free Fatty Acid Activation FFA + CoA + 2 ATP → FAC + 2 ADP + 2 Pi
φFFAFAC=VFFAFAC(CATPCADPKATPADP+CATPCADP)(CFFAKFFACCoAKCoA1+CFFAKFFA+CCoAKCoA+CFFAKFFACCoAKCoA+CFACKFAC+CPiKPi+CFACKFACCPiKPi) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@C67B@
This is lumping of 2 reactions FFA + CoA + ATP → FAC + AMP + 2Pi and AMP + ATP ↔ 2 ADP.
14. Fatty Acyl-CoA Oxidation FAC + 7 CoA + (35/3) NAD+ → 8 ACoA + (35/3) NADH
φFACACoA=VFACACoA(CNAD+CNADHKNAD+NADH+CNAD+CNADH)(CFACKFACCCoAKCoA1+CFACKFAC+CCoAKCoA+CFACKFACCCoAKCoA+CACoAKACoA) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@B549@
This reaction producing ACoA from the activated fatty acid inside the mitochondrial matrix is highly complex. It is the result of combining 7 cycles of reactions in which each cycle consists of 4 enzymatic reactions. For simplicity, FAD and FADH2 are considered equivalent to 2/3 NAD+ and 2/3 NADH in terms of the amount of ATP production (though they consume equal amount of O2).
15. Citrate Production ACoA + OXA → CIT + CoA
φACoACIT=VACoACIT(CACoAKACoACOXAKOXA1+CACoAKACoA+COXAKOXA+CACoAKACoACOXAKOXA+CCITKCIT+CCoAKCoA+CCITKCITCCoAKCoA) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFgpGzlmaaBaaabaGaeeyqaeKaee4qamKaee4Ba8MaeeyqaeKaeyOKH4Qaee4qamKaeeysaKKaeeivaqfabeaakiabg2da9iabdAfawnaaBaaaleaacqqGbbqqcqqGdbWqcqqGVbWBcqqGbbqqcqGHsgIRcqqGdbWqcqqGjbqscqqGubavaOqabaWaaeWaaeaadaWcaaqaamaalaaabaGaem4qam0aaSbaaSqaaiabbgeabjabboeadjabb+gaVjabbgeabbGcbeaaaeaacqWGlbWsdaWgaaWcbaGaeeyqaeKaee4qamKaee4Ba8MaeeyqaeeakeqaaaaacqGHflY1daWcaaqaaiabdoeadnaaBaaaleaacqqGpbWtcqqGybawcqqGbbqqaOqabaaabaGaem4saS0aaSbaaSqaaiabb+eapjabbIfayjabbgeabbGcbeaaaaaabaGaeeymaeJaey4kaSYaaSaaaeaacqWGdbWqdaWgaaWcbaGaeeyqaeKaee4qamKaee4Ba8MaeeyqaeeakeqaaaqaaiabdUealnaaBaaaleaacqqGbbqqcqqGdbWqcqqGVbWBcqqGbbqqaOqabaaaaiabgUcaRmaalaaabaGaem4qam0aaSbaaSqaaiabb+eapjabbIfayjabbgeabbGcbeaaaeaacqWGlbWsdaWgaaWcbaGaee4ta8KaeeiwaGLaeeyqaeeakeqaaaaacqGHRaWkdaWcaaqaaiabdoeadnaaBaaaleaacqqGbbqqcqqGdbWqcqqGVbWBcqqGbbqqaOqabaaabaGaem4saS0aaSbaaSqaaiabbgeabjabboeadjabb+gaVjabbgeabbGcbeaaaaGaeyyXIC9aaSaaaeaacqWGdbWqdaWgaaWcbaGaee4ta8KaeeiwaGLaeeyqaeeakeqaaaqaaiabdUealnaaBaaaleaacqqGpbWtcqqGybawcqqGbbqqaOqabaaaaiabgUcaRmaalaaabaGaem4qam0aaSbaaSqaaiabboeadjabbMeajjabbsfaubGcbeaaaeaacqWGlbWsdaWgaaWcbaGaee4qamKaeeysaKKaeeivaqfakeqaaaaacqGHRaWkdaWcaaqaaiabdoeadnaaBaaaleaacqqGdbWqcqqGVbWBcqqGbbqqaOqabaaabaGaem4saS0aaSbaaSqaaiabboeadjabb+gaVjabbgeabbGcbeaaaaGaey4kaSYaaSaaaeaacqWGdbWqdaWgaaWcbaGaee4qamKaeeysaKKaeeivaqfakeqaaaqaaiabdUealnaaBaaaleaacqqGdbWqcqqGjbqscqqGubavaOqabaaaaiabgwSixpaalaaabaGaem4qam0aaSbaaSqaaiabboeadjabb+gaVjabbgeabbGcbeaaaeaacqWGlbWsdaWgaaWcbaGaee4qamKaee4Ba8MaeeyqaeeakeqaaaaaaaaacaGLOaGaayzkaaaaaa@B8A5@
16. α-Ketoglutarate Production CIT + NAD+ → AKG + NADH + CO2
φCITAKG=VCITAKG(CNAD+CNADHKNAD+NADH+CNAD+CNADH)(CCITKCIT1+CCITKCIT+CAKGKAKG+CCO2KCO2+CAKGKAKGCCO2KCO2) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@A3EA@
This is lumping of 2 enzymatic reactions CIT ↔ ICIT and ICIT + NAD+ → AKG + CO2 + NADH.
17. Succinyl-CoA Production AKG + CoA + NAD+ → SCoA + NADH + CO2
φAKGSCoA=VAKGSCoA(CNAD+CNADHKNAD+NADH+CNAD+CNADH)(CAKGKAKGCCoAKCoA1+CAKGKAKG+CCoAKCoA+CAKGKAKGCCoAKCoA+CSCoAKSCoA+CCO2KCO2+CSCoAKSCoACCO2KCO2) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@D834@
18. Succinate Production SCoA + ADP + Pi → SUC + CoA + ATP
φSCoASUC=VSCoASUC(CADPCATPKADPATP+CADPCATP)(CSCoAKSCoACPiKPi1+CSCoAKSCoA+CPiKPi+CSCoAKSCoACPiKPi+CSUCKSUC+CCoAKCoA+CSUCKSUCCCoAKCoA) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@D1D9@
Because the reaction GTP + ADP ↔ GDP + ATP is in fast equilibrium, we assume the GTP/GDP ratio proportional to the ATP/ADP ratio.
19. Malate Production SUC + (2/3) NAD+ → MAL + (2/3) NADH
φSUCMAL=VSUCMAL(CNAD+CNADHKNAD+NADH+CNAD+CNADH)(CSUCKSUC1+CSUCKSUC+CMALKMAL) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@85B0@
This is lumping of 2 reactions SUC + FAD → FUM + FADH2 and FUM ↔ MAL. FAD and FADH2 are considered equivalent to 2/3 NAD+ and 2/3 NADH.
20. Oxaloacetate Production MAL + NAD+ → OXA + NADH
φMALOXA=VMALOXA(CNAD+CNADHKNAD+NADH+CNAD+CNADH)(CMALKMAL1+CMALKMAL+COXAKOXA) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@8554@
21. Oxygen Utilization O2 + 5.64 ADP + 5.64 Pi + 1.88 NADH → 2 H2O + 5.64 ATP + 1.88 NAD+
φO2H2O=VO2H2O(CADPCATPKADPATP+CADPCATP)(CO2KO2CPiKPiCNADHKNADH1+CO2KO2+CPiKPi+CNADHKNADH+CO2KO2CPiKPiCNADHKNADH+CNAD+KNAD+) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@C4D9@
This is a sum of several enzymatic reactions at complex I – V that constitute the electron transport chain and oxidative phosphorylation in the mitochondrial matrix. FAD and FADH2 are considered equivalent to 2/3 NAD+ and 2/3 NADH. Unlike other reactions, here NADH and NAD+ are treated as substrates rather than controllers. Furthermore, 1 NADH is assumed to produce 3 ATP (i.e., P/O ratio = 3 for substrate NADH). To account for the proton leak, the stoichiometries for NADH and NAD+ are adjusted to 1.88 and that for ATP, ADP and Pi are accordingly adjusted to 3*1.88 = 5.64.
22. Phosphocreatine Breakdown PCR + ADP → CR + ATP
φPCRCR=VPCRCR(CADPCATPKADPATP+CADPCATP)(CPCRKPCR1+CPCRKPCR+CCRKCR) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@7B39@
23. Phosphocreatine Synthesis CR + ATP → PCR + ADP
φCRPCR=VCRPCR(CATPCADPKATPADP+CATPCADP)(CCRKCR1+CCRKCR+CPCRKPCR) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@78EF@
24. ATP Hydrolysis ATP → ADP + Pi
φATPADP=VATPADP(CATPKATP1+CATPKATP) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@5864@
25. AMP Utilization AMP + ATP → 2 ADP
φAMPADP=VAMPADP(CAMPKAMPCATPKATP1+CAMPKAMP+CATPKATP+CAMPKAMPCATPKATP+CADPKADP) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@8DEF@
26. AMP Production 2 ADP → AMP + ATP
φADPAMP=VADPAMP(CADPKADP1+CADPKADP+CAMPKAMP+CATPKATP+CAMPKAMPCATPKATP) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@8219@

Acknowledgments

Acknowledgements

This research was supported by grants from the National Aeronautics and Space Administration (NASA – Johnson Space Center NNJ06HD81G) and the National Institute of General Medical Sciences of the National Institute of Health (GM-66309). We are thankful to Krishnan Radhakrishnan for his fruitful discussion of this manuscript and the reviewers for their constructive criticisms.

Contributor Information

Ranjan K Dash, Email: rdash@mcw.edu.

John A DiBella, II, Email: john.dibella@case.edu.

Marco E Cabrera, Email: mec6@cwru.edu.

References

  1. Baldwin KM, Caiozzo VJ, Haddad F, Baker MJ, Herrick RE. The effects of space flight on the contractile apparatus of antigravity muscles: implications for aging and deconditioning. J Gravit Physiol. 1994;1:8–11. [PubMed] [Google Scholar]
  2. Baldwin KM, Haddad F. Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol. 2001;90:345–357. doi: 10.1063/1.1372658. [DOI] [PubMed] [Google Scholar]
  3. Baldwin KM, Haddad F. Skeletal muscle plasticity: cellular and molecular responses to altered physical activity paradigms. Am J Phys Med Rehabil. 2002;81:S40–S51. doi: 10.1097/00002060-200211001-00006. [DOI] [PubMed] [Google Scholar]
  4. Bickel CS, Slade J, Mahoney E, Haddad F, Dudley GA, Adams GR. Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise. J Appl Physiol. 2005;98:482–488. doi: 10.1152/japplphysiol.00895.2004. [DOI] [PubMed] [Google Scholar]
  5. Haddad F, Qin AX, Zeng M, McCue SA, Baldwin KM. Effects of isometric training on skeletal myosin heavy chain expression. J Appl Physiol. 1998;84:2036–2041. doi: 10.1152/jappl.1998.84.6.2036. [DOI] [PubMed] [Google Scholar]
  6. Green HJ, Jones S, Ball-Burnett ME, Smith D, Livesey J, Farrance BW. Early muscular and metabolic adaptations to prolonged exercise training in humans. J Appl Physiol. 1991;70:2032–2038. doi: 10.1152/jappl.1991.70.5.2032. [DOI] [PubMed] [Google Scholar]
  7. Green HJ, Jones S, Ball-Burnett M, Farrance B, Ranney D. Adaptations in muscle metabolism to prolonged voluntary exercise and training. J Appl Physiol. 1995;78:138–145. doi: 10.1152/jappl.1995.78.1.138. [DOI] [PubMed] [Google Scholar]
  8. Klausen K, Anderson LB, Pelle I. Adaptive changes in work capacity, skeletal muscle capillarization and enzyme levels during training and detraining. Acta Physiol Scand. 1980;113:9–16. doi: 10.1111/j.1748-1716.1981.tb06854.x. [DOI] [PubMed] [Google Scholar]
  9. Maughan R, Gleeson M, Greenhaff PL. Biochemistry of exercise & Training. New York: Oxford University Press; 1997. [Google Scholar]
  10. Morgan TE, Cobb LA, Short FA, Ross R, Gunn DR. Muscle metabolism during exercise (ed B Pernow and B Saltin), Plenum Press, NY; 1971. Effects of long term exercise on human muscle mitochondria; pp. 87–95. [Google Scholar]
  11. Phillips SM, Green HJ, Tarnopolsky MA, Heigenhauser GJ, Grant SM. Progressive effect of endurance training on metabolic adaptations in working skeletal muscle. Am J Physiol Endocrinol Metab. 1996;270:E265–E272. doi: 10.1152/ajpendo.1996.270.2.E265. [DOI] [PubMed] [Google Scholar]
  12. Bergman BC, Butterfield GE, Wolfel EE, Lopaschuk GD, Casazza GA, Horning MA, Brooks GA. Muscle net glucose uptake and glucose kinetics after endurance training in men. Am J Physiol Endocrinol Metab. 1999;277:E81–E92. doi: 10.1152/ajpendo.1999.277.1.E81. [DOI] [PubMed] [Google Scholar]
  13. Bergman BC, Wolfel EE, Butterfield GE, Lopaschuk GD, Casazza GA, Horning MA, Brooks GA. Active muscle and whole body lactate kinetics after endurance training in men. J Appl Physiol. 1999;87:1684–1696. doi: 10.1152/jappl.1999.87.5.1684. [DOI] [PubMed] [Google Scholar]
  14. Putman CT, Jones NL, Heigenhauser GJ. Effects of short-term training on plasma acid-base balance during incremental exercise in man. J Physiol. 2003;550:585–603. doi: 10.1113/jphysiol.2003.039743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bergman BC, Butterfield GE, Wolfel EE, Casazza GA, Lopaschuk GD, Brooks GA. Evaluation of exercise and training on muscle lipid metabolism. Am J Physiol Endocrinol Metab. 1999;276:E106–E117. doi: 10.1152/ajpendo.1999.276.1.E106. [DOI] [PubMed] [Google Scholar]
  16. Costill DL, Fink WJ, Getchell LH, Ivy JL, Witzmann FA. Lipid metabolism in skeletal muscle of endurance-trained males and females. J Appl Physiol. 1979;47:787–791. doi: 10.1152/jappl.1979.47.4.787. [DOI] [PubMed] [Google Scholar]
  17. Hurley BF, Nemeth PM, Martin WH, III, Hagberg JM, Dalsky GP, Holloszy JO. Muscle triglyceride utilization during exercise: effect of training. J Appl Physiol. 1986;60:562–567. doi: 10.1152/jappl.1986.60.2.562. [DOI] [PubMed] [Google Scholar]
  18. Turcotte LP, Richter EA, Kiens B. Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. untrained humans. Am J Physiol Endocrinol Metab. 1992;262:E791–E799. doi: 10.1152/ajpendo.1992.262.6.E791. [DOI] [PubMed] [Google Scholar]
  19. Schantz PG. Plasticity of human skeletal muscle with special reference to effects of physical training on enzyme levels of the NADH shuttles and phenotypic expression of slow and fast myofibrillar proteins. Acta Physiol Scand Suppl. 1986;558:62. [PubMed] [Google Scholar]
  20. Tikkanen HO, Hamalainen E, Harkonen M. Significance of skeletal muscle properties on fitness, long-term physical training and serum lipids. Atherosclerosis. 1999;142:367–378. doi: 10.1016/S0021-9150(98)00261-5. [DOI] [PubMed] [Google Scholar]
  21. Convertino VA, Doerr DF, Mathes KL, Stein SL, Buchanan P. Changes in Volume, muscle compartment, and compliance of the lower extremities in man followin 30 days of exposure to simulated microgravity. Aviat Space Environ med. 1989;60:653–658. [PubMed] [Google Scholar]
  22. Coyle EF, Martin WH, III, Bloomfield SA, Lowry OH, Holloszy JO. Effects of detraining on responses to submaximal exercise. J Appl Physiol. 1985;59:853–859. doi: 10.1152/jappl.1985.59.3.853. [DOI] [PubMed] [Google Scholar]
  23. Hikida RS, Gollnick PD, Dudley GA, Convertino VA, Buchanan P. Structural and metabolic characteristics of human skeletal muscle following 30 days of simulated microgravity. Aviat Space Environ med. 1989;60:670. [PubMed] [Google Scholar]
  24. Mujika I, Padilla S. Muscular characteristics of detraining in humans. Med Sci Sports Exerc. 2001;33:1297–1303. doi: 10.1097/00005768-200108000-00009. [DOI] [PubMed] [Google Scholar]
  25. Fitts RH, Riley DR., Widrick,JJ Functional and structural adaptions of skeletal muscle to microgravity. J Exp Biol. 2001;204:3201–3208. doi: 10.1242/jeb.204.18.3201. [DOI] [PubMed] [Google Scholar]
  26. Bylund-Fellenius AC, Walker PM, Elander A, Holm S, Holm J, Schersten T. Energy metabolism in relation to oxygen partial pressure in human skeletal muscle during exercise. Biochem J. 1981;200:247–255. doi: 10.1042/bj2000247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hickson RC, Bomze HA, Hollozy JO. Faster adjustment of O2 uptake to the energy requirement of exercise in the trained state. J Appl Physiol. 1978;44:877–881. doi: 10.1152/jappl.1978.44.6.877. [DOI] [PubMed] [Google Scholar]
  28. Cabrera ME, Saidel GM, Kalhan SC. Role of O2 in regulation of lactate dynamics during hypoxia: mathematical model and analysis. Ann Biomed Eng. 1998;26:1–27. doi: 10.1114/1.28. [DOI] [PubMed] [Google Scholar]
  29. Cabrera ME, Saidel GM, Kalhan SC. Lactate metabolism during exercise: analysis by an integrative systems model. Am J Physiol. 1999;277:R1522–R1536. doi: 10.1152/ajpregu.1999.277.5.R1522. [DOI] [PubMed] [Google Scholar]
  30. Segel IH. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. Wiley-Interscience, New York; 1993. [Google Scholar]
  31. Fell D. Understanding the Control of Metabolism. Portland Press, London; 1996. [Google Scholar]
  32. Cabrera ME, Saidel GM, Kalhan SC. Modeling metabolic dynamics from cellular processes to organ and whole body responses. Prog Biophys Molec Biol. 1998;69:539–557. doi: 10.1016/S0079-6107(98)00024-8. [DOI] [PubMed] [Google Scholar]
  33. Nelson DS, Cox MM. Lehninger Principles of Biochemistry (third edition) Worth Publishers, New York; 2000. [Google Scholar]
  34. Korzeniewski B. Regulation of ATP supply during muscle contraction: theoretical studies. Biochem J. 1998;330:1189–1195. doi: 10.1042/bj3301189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Korzeniewski B. Regulation of ATP supply in mammalian skeletal muscle during resting state intensive work transition. Biophys Chem. 2000;83:19–34. doi: 10.1016/S0301-4622(99)00120-9. [DOI] [PubMed] [Google Scholar]
  36. Korzeniewski B, Zoladz JA. A model of oxidative phosphorylation in mammalian skeletal muscle. Biophys Chem. 2001;92:17–34. doi: 10.1016/S0301-4622(01)00184-3. [DOI] [PubMed] [Google Scholar]
  37. Korzeniewski B. Theoretical studies on the regulation of oxidative phosphorylation in intact tissues. Biochim Biophys Acta. 2001;1504:31–45. doi: 10.1016/S0005-2728(00)00237-1. [DOI] [PubMed] [Google Scholar]
  38. Denton RM, McCormack JG, Rutter GA, Burnett P, Edgell NJ, Moule SK, Diggle TA. The hormonal regulation of pyruvate dehydrogenase complex. Adv Enzyme Regul. 1996;36:183–198. doi: 10.1016/0065-2571(95)00020-8. [DOI] [PubMed] [Google Scholar]
  39. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev. 1990;70:391–425. doi: 10.1152/physrev.1990.70.2.391. [DOI] [PubMed] [Google Scholar]
  40. Balaban RS, Bose S, French SA, Territo PR. Role of calcium in metabolic signaling between cardiac sarcoplasmic reticulum and mitochondria in vitro. Am J Physiol Cell Physiol. 2003;284:C285–C293. doi: 10.1152/ajpcell.00129.2002. [DOI] [PubMed] [Google Scholar]
  41. Radegran G, Blomstrand E, Saltin B. Peak muscle perfusion and oxygen uptake in humans: importance of precise estimates of muscle mass. J Appl Physiol. 1999;87:2375–2380. doi: 10.1152/jappl.1999.87.6.2375. [DOI] [PubMed] [Google Scholar]
  42. Ray CA, Dudley GA. Muscle use during dynamic knee extension: implication for perfusion and metabolism. J Appl Physiol. 1998;85:1194–1197. doi: 10.1152/jappl.1998.85.3.1194. [DOI] [PubMed] [Google Scholar]
  43. Ahlborg G, Felig P, Hagenfeldt L, Hendler R, Wahren J. Substrate turnover during prolonged exercise in man. J Clin Invest. 1974;53:1080–1090. doi: 10.1172/JCI107645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Connett RJ. Glycolytic regulation during an aerobic rest-to-work transition in dog gracilis muscle. J Appl Physiol. 1987;63:2366–2374. doi: 10.1152/jappl.1987.63.6.2366. [DOI] [PubMed] [Google Scholar]
  45. Wahren J, Felig P, Ahlborg G, Jorfeldt L. Glucose metabolism during leg exercise in man. J Clin Invest. 1971;50:2715–2725. doi: 10.1172/JCI106772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Dash RK, Bassingthwaighte JB. Simultaneous blood-tissue exchange of oxygen, carbon dioxide, bicarbonate, and hydrogen ion. Ann Biomed Eng. 2006;34:1129–1148. doi: 10.1007/s10439-005-9066-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Salem JE, Saidel GM, Stanley WC, Cabrera ME. Mechanistic model of myocardial metabolism under normal and ischemic conditions. Ann Biomed Eng. 2002;30:202–216. doi: 10.1114/1.1454133. [DOI] [PubMed] [Google Scholar]
  48. Zhou L, Salem JE, Saidel GM, Stanley WC, Cabrera ME. Mechanistic model of cardiac energy metabolism predicts localization of glycolysis to cytosolic subdomain during ischemia. Am J Physiol Heart Circ Physiol. 2005;288:H2400–H2411. doi: 10.1152/ajpheart.01030.2004. [DOI] [PubMed] [Google Scholar]
  49. Lambeth MJ, Kushmerick MJ. Computational model for glycogenolysis in skeletal muscle. Ann Biomed Eng. 2002;30:808–827. doi: 10.1114/1.1492813. [DOI] [PubMed] [Google Scholar]
  50. Vinnakota K, Kemp ML, Kushmerick MJ. Dynamics of muscle glycogenolysis modeled with pH time course computation and pH-dependent reaction equilibria and enzyme kinetics. Biophys J. 2006;91:1264–1287. doi: 10.1529/biophysj.105.073296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Howlett RA, Parolin ML, Dyck DJ, Hultman E, Jones NL, Heigenhauser GJF, Spriet LL. Regulation of skeletal muscle glycogen phosphorylase and PDH at varying exercise power outputs. Am J Physiol. 1998;275:R418–R425. doi: 10.1152/ajpregu.1998.275.2.R418. [DOI] [PubMed] [Google Scholar]
  52. Hochachka PW, Matheson GO. Regulating ATP turnover rates over broad dynamic work ranges in skeletal muscle. J Appl Physiol. 1992;73:1697–1703. doi: 10.1152/jappl.1992.73.5.1697. [DOI] [PubMed] [Google Scholar]
  53. Shoemaker JK, Phillips SM, Green HJ, Hughson RL. Faster femoral artery blood velocity kinetics at the onset of exercise following short-term training. Cardiovasc Res. 1996;31:278–286. doi: 10.1016/0008-6363(95)00199-9. [DOI] [PubMed] [Google Scholar]
  54. Gaesser GA, Brooks GA. Muscular efficiency during steady-rate exercise: effects of speed and work rate. J Appl Physiol. 1975;38:1132–1139. doi: 10.1152/jappl.1975.38.6.1132. [DOI] [PubMed] [Google Scholar]
  55. Hindmarsh AC. ODEPACK: A systemized collection of ode solvers In Scientific Computing, edited by R Stepleman. North-Holland: Amsterdam; 1983. [Google Scholar]
  56. Blomstrand E, Saltin B. Effect of muscle glycogen on glucose, lactate, and amino acid metabolism during exercise and recovery in human subjects. J Physiol. 1999;514:293–302. doi: 10.1111/j.1469-7793.1999.293af.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Gibala MJ, MacLean DA, Graham TE, Saltin B. Tricarboxylic acid cycle intermediate pool size and estimated cycle flux in human muscle during exercise. Am J Physiol. 1998;275:E235–E242. doi: 10.1152/ajpendo.1998.275.2.E235. [DOI] [PubMed] [Google Scholar]
  58. Katz A. G-1,6-P2, glycolysis, and energy metabolism during circulatory occlusion in human skeletal muscle. Am J Physiol Cell Physiol. 1988;255:C140–C144. doi: 10.1152/ajpcell.1988.255.2.C140. [DOI] [PubMed] [Google Scholar]
  59. Ren JM, Henriksson J, Katz A, Sahlin K. NADH content in type I and type II human muscle fibres after dynamic exercise. Biochem J. 1988;251:183–187. doi: 10.1042/bj2510183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Sahlin K, Katz A, Henriksson J. Redox state and lactate accumulation in human skeletal muscle during dynamic exercise. Biochem J. 1987;245:551–556. doi: 10.1042/bj2450551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Chasiotis D, Hultman E. The effect of circulatory occlusion on the glycogen phosphorylase-synthetase system in human skeletal muscle. J Physiol. 1983;345:167–173. doi: 10.1113/jphysiol.1983.sp014972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Mikines KJ, Richter EA, Dela F, Galbo H. Seven days of bed rest decrease insulin action on glucose uptake in leg and whole body. J Appl Physiol. 1991;70:1245–1254. doi: 10.1152/jappl.1991.70.3.1245. [DOI] [PubMed] [Google Scholar]
  63. Wibom R, Hultman E, Johansson M, Matherei K, Constantin-Teodosiu D, Schantz PG. Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining. J Appl Physiol. 1992;73:2004–2010. doi: 10.1152/jappl.1992.73.5.2004. [DOI] [PubMed] [Google Scholar]
  64. Putman CT, Jones NL, Hultman E, Hollidge-Horvat MG, Bonen A, McConachie DR, Heigenhauser GJ. Effects of short-term submaximal training in humans on muscle metabolism in exercise. Am J Physiol Endocrinol Metab. 1998;275:E132–E139. doi: 10.1152/ajpendo.1998.275.1.E132. [DOI] [PubMed] [Google Scholar]
  65. Watt MJ, Heigenhauser GJF, Spriet LL. Effects of dynamic exercise intensity on the activation of hormone-sensitive lipase in human skeletal muscle. J Physiol. 2003;574:308. doi: 10.1113/jphysiol.2002.034595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Brooks GA, Fahey TD, Baldwin KM. Exercise Physiology: Human Bioenergetics and its Applications (fourth edition) Mayfield Publishing Company, Mountain View, CA; 2004. [Google Scholar]
  67. Jensen MD, Nguyen TT, Mijares AH, Johnson CM, Murray MJ. Effects of gender on resting leg blood flow: implications for measurement of regional substrate oxidation. J Appl Physiol. 1998;84:141–145. doi: 10.1152/jappl.1998.84.1.141. [DOI] [PubMed] [Google Scholar]
  68. Grassi B. Skeletal muscle VO2 on -kinetics: set by O2 delivery or by O2 utilization? New insights into an old issue. Med Sci Sports Exerc. 2000;32:108–116. doi: 10.1097/00005768-200001000-00017. [DOI] [PubMed] [Google Scholar]
  69. Whipp BJ, Wasserman K. Efficiency of muscular work. J Appl Physiol. 1969;26:648. doi: 10.1152/jappl.1969.26.5.644. [DOI] [PubMed] [Google Scholar]
  70. Rossiter HB, Ward SA, Doyle VL, Howe FA, Griffiths JR, Whipp BJ. Inferences from pulmonary O2 uptake with respect to intramuscular [phosphocreatine] kinetics during moderate exercise in humans. J Physiol. 1999;518 ( Pt 3):921–932. doi: 10.1111/j.1469-7793.1999.0921p.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Rossiter HB, Ward SA, Kowalchuk JM, Howe FA, Griffiths JR, Whipp BJ. Dynamic asymmetry of phosphocreatine concentration and O(2) uptake between the on- and off-transients of moderate- and high-intensity exercise in humans. J Physiol. 2002;541:991–1002. doi: 10.1113/jphysiol.2001.012910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Chung Y, Mole PA, Sailasuta N, Tran TK, Hurd R, Jue T. Control of respiration and bioenergetics during muscle contraction. AJP - Cell Physiology. 2005;288:C730–C738. doi: 10.1152/ajpcell.00138.2004. [DOI] [PubMed] [Google Scholar]
  73. Hamaoka T, Iwane H, Shimomitsu T, Katsumura T, Murase N, Nishio S, Osada T, Kurosawa Y, Chance B. Noninvasive measures of oxidative metabolism on working human muscles by near-infrared spectroscopy. J Appl Physiol. 1996;81:1410–1417. doi: 10.1152/jappl.1996.81.3.1410. [DOI] [PubMed] [Google Scholar]
  74. Bose S, French S, Evans FJ, Joubert F, Balaban RS. Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate. J Biol Chem. 2003;278:39155–39165. doi: 10.1074/jbc.M306409200. [DOI] [PubMed] [Google Scholar]
  75. Spriet LL, Howlett RA, Heigenhauser GJF. An enzymatic approach to lactate production in human skeletal muscle during exercise. Med Sci Sports Exerc. 2000;32:756–763. doi: 10.1097/00005768-200004000-00007. [DOI] [PubMed] [Google Scholar]
  76. Radegran G, Saltin B. Muscle blood flow at onset of dynamic exercise in humans. Am J Physiol. 1998;274:H314–H322. doi: 10.1152/ajpheart.1998.274.1.H314. [DOI] [PubMed] [Google Scholar]
  77. Convertino VA, Glodwater DJ, Sandler H. VO2 kinetics of constant-load exercise following bed-rest induced deconditioning. J Appl Physiol. 1984;57:1545–1550. doi: 10.1152/jappl.1984.57.5.1545. [DOI] [PubMed] [Google Scholar]

Articles from BioMedical Engineering OnLine are provided here courtesy of BMC

RESOURCES